<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>(phospholipid synapse) or (phospholipids synapse)</title>
    <link>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;ff=20220524190436&amp;utm_source=Other&amp;v=2.17.6&amp;utm_medium=rss</link>
    <description>(phospholipid synapse) or (phospholipids synapse): Latest results from PubMed</description>
    <atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;ff=20220524190436&amp;utm_source=Other&amp;v=2.17.6&amp;utm_medium=rss" rel="self"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>PubMed RSS feeds (2.17.6)</generator>
    <language>en</language>
    <lastBuildDate>Tue, 24 May 2022 23:04:38 +0000</lastBuildDate>
    <pubDate>Fri, 08 Apr 2022 06:00:00 -0400</pubDate>
    <ttl>120</ttl>
    <item>
      <title>LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35394866/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Cancer and chronic infections often increase levels of the bioactive lipid, lysophosphatidic acid (LPA), that we have demonstrated acts as an inhibitory ligand upon binding LPAR5 on CD8 T cells, suppressing cytotoxic activity and tumor control. This study, using human and mouse primary T lymphocytes, reveals how LPA disrupts antigen-specific CD8 T cell:target cell immune synapse (IS) formation and T cell function via competing for cytoskeletal regulation. Specifically, we find upon...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Proc Natl Acad Sci U S A. 2022 Apr 12;119(15):e2118816119. doi: 10.1073/pnas.2118816119. Epub 2022 Apr 8.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cancer and chronic infections often increase levels of the bioactive lipid, lysophosphatidic acid (LPA), that we have demonstrated acts as an inhibitory ligand upon binding LPAR5 on CD8 T cells, suppressing cytotoxic activity and tumor control. This study, using human and mouse primary T lymphocytes, reveals how LPA disrupts antigen-specific CD8 T cell:target cell immune synapse (IS) formation and T cell function via competing for cytoskeletal regulation. Specifically, we find upon antigen-specific T cell:target cell formation, IP3R1 localizes to the IS by a process dependent on mDia1 and actin and microtubule polymerization. LPA not only inhibited IP3R1 from reaching the IS but also altered T cell receptor (TCR)–induced localization of RhoA and mDia1 impairing F-actin accumulation and altering the tubulin code. Consequently, LPA impeded calcium store release and IS-directed cytokine secretion. Thus, targeting LPA signaling in chronic inflammatory conditions may rescue T cell function and promote antiviral and antitumor immunity.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35394866/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">35394866</a> | DOI:<a href=https://doi.org/10.1073/pnas.2118816119>10.1073/pnas.2118816119</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35394866</guid>
      <pubDate>Fri, 08 Apr 2022 06:00:00 -0400</pubDate>
      <dc:creator>Kimberly N Kremer</dc:creator>
      <dc:creator>Alan Buser</dc:creator>
      <dc:creator>Dean Thumkeo</dc:creator>
      <dc:creator>Shuh Narumiya</dc:creator>
      <dc:creator>Jordan Jacobelli</dc:creator>
      <dc:creator>Roberta Pelanda</dc:creator>
      <dc:creator>Raul M Torres</dc:creator>
      <dc:date>2022-04-08</dc:date>
      <dc:source>Proceedings of the National Academy of Sciences of the United States of America</dc:source>
      <dc:title>LPA suppresses T cell function by altering the cytoskeleton and disrupting immune synapse formation</dc:title>
      <dc:identifier>pmid:35394866</dc:identifier>
      <dc:identifier>doi:10.1073/pnas.2118816119</dc:identifier>
    </item>
    <item>
      <title>Multiple Mild Stimulations Reduce Membrane Distribution of CX3CR1 Promoted by Annexin a1 in Microglia to Attenuate Excessive Dendritic Spine Pruning and Cognitive Deficits Caused by a Transient Ischemic Attack in Mice</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35352285/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>A transient ischemic attack (TIA) can cause reversible and delayed impairment of cognition, but the specific mechanisms are still unclear. Annexin a1 (ANXA1) is a phospholipid-binding protein. Here, we confirmed that cognition and hippocampal synapses were impaired in TIA-treated mice, and this could be rescued by multiple mild stimulations (MMS). TIA promoted the interaction of ANXA1 and CX3CR1, increased the membrane distribution of CX3CR1 in microglia, and thus enhanced the CX3CR1 and CX3CL1...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Neurosci Bull. 2022 Mar 30. doi: 10.1007/s12264-022-00847-4. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A transient ischemic attack (TIA) can cause reversible and delayed impairment of cognition, but the specific mechanisms are still unclear. Annexin a1 (ANXA1) is a phospholipid-binding protein. Here, we confirmed that cognition and hippocampal synapses were impaired in TIA-treated mice, and this could be rescued by multiple mild stimulations (MMS). TIA promoted the interaction of ANXA1 and CX3CR1, increased the membrane distribution of CX3CR1 in microglia, and thus enhanced the CX3CR1 and CX3CL1 interaction. These phenomena induced by TIA could be reversed by MMS. Meanwhile, the CX3CR1 membrane distribution and CX3CR1-CX3CL1 interaction were upregulated in primary cultured microglia overexpressing ANXA1, and the spine density was significantly reduced in co-cultured microglia overexpressing ANXA1 and neurons. Moreover, ANXA1 overexpression in microglia abolished the protection of MMS after TIA. Collectively, our study provides a potential strategy for treating the delayed synaptic injury caused by TIA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35352285/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">35352285</a> | DOI:<a href=https://doi.org/10.1007/s12264-022-00847-4>10.1007/s12264-022-00847-4</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35352285</guid>
      <pubDate>Wed, 30 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Lu Zheng</dc:creator>
      <dc:creator>Yi Wang</dc:creator>
      <dc:creator>Bin Shao</dc:creator>
      <dc:creator>Huijuan Zhou</dc:creator>
      <dc:creator>Xing Li</dc:creator>
      <dc:creator>Cai Zhang</dc:creator>
      <dc:creator>Ning Sun</dc:creator>
      <dc:creator>Jing Shi</dc:creator>
      <dc:date>2022-03-30</dc:date>
      <dc:source>Neuroscience bulletin</dc:source>
      <dc:title>Multiple Mild Stimulations Reduce Membrane Distribution of CX3CR1 Promoted by Annexin a1 in Microglia to Attenuate Excessive Dendritic Spine Pruning and Cognitive Deficits Caused by a Transient Ischemic Attack in Mice</dc:title>
      <dc:identifier>pmid:35352285</dc:identifier>
      <dc:identifier>doi:10.1007/s12264-022-00847-4</dc:identifier>
    </item>
    <item>
      <title>Endosomal phosphatidylinositol 3-phosphate controls synaptic vesicle cycling and neurotransmission</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35318705/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Neural circuit function requires mechanisms for controlling neurotransmitter release and the activity of neuronal networks, including modulation by synaptic contacts, synaptic plasticity, and homeostatic scaling. However, how neurons intrinsically monitor and feedback control presynaptic neurotransmitter release and synaptic vesicle (SV) recycling to restrict neuronal network activity remains poorly understood at the molecular level. Here, we investigated the reciprocal interplay between...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2022 May 2;41(9):e109352. doi: 10.15252/embj.2021109352. Epub 2022 Mar 22.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neural circuit function requires mechanisms for controlling neurotransmitter release and the activity of neuronal networks, including modulation by synaptic contacts, synaptic plasticity, and homeostatic scaling. However, how neurons intrinsically monitor and feedback control presynaptic neurotransmitter release and synaptic vesicle (SV) recycling to restrict neuronal network activity remains poorly understood at the molecular level. Here, we investigated the reciprocal interplay between neuronal endosomes, organelles of central importance for the function of synapses, and synaptic activity. We show that elevated neuronal activity represses the synthesis of endosomal lipid phosphatidylinositol 3-phosphate [PI(3)P] by the lipid kinase VPS34. Neuronal activity in turn is regulated by endosomal PI(3)P, the depletion of which reduces neurotransmission as a consequence of perturbed SV endocytosis. We find that this mechanism involves Calpain 2-mediated hyperactivation of Cdk5 downstream of receptor- and activity-dependent calcium influx. Our results unravel an unexpected function for PI(3)P-containing neuronal endosomes in the control of presynaptic vesicle cycling and neurotransmission, which may explain the involvement of the PI(3)P-producing VPS34 kinase in neurological disease and neurodegeneration.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35318705/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">35318705</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC9058544/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC9058544</a> | DOI:<a href=https://doi.org/10.15252/embj.2021109352>10.15252/embj.2021109352</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35318705</guid>
      <pubDate>Wed, 23 Mar 2022 06:00:00 -0400</pubDate>
      <dc:creator>Guan-Ting Liu</dc:creator>
      <dc:creator>Gaga Kochlamazashvili</dc:creator>
      <dc:creator>Dmytro Puchkov</dc:creator>
      <dc:creator>Rainer Müller</dc:creator>
      <dc:creator>Carsten Schultz</dc:creator>
      <dc:creator>Albert I Mackintosh</dc:creator>
      <dc:creator>Dennis Vollweiter</dc:creator>
      <dc:creator>Volker Haucke</dc:creator>
      <dc:creator>Tolga Soykan</dc:creator>
      <dc:date>2022-03-23</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>Endosomal phosphatidylinositol 3-phosphate controls synaptic vesicle cycling and neurotransmission</dc:title>
      <dc:identifier>pmid:35318705</dc:identifier>
      <dc:identifier>pmc:PMC9058544</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2021109352</dc:identifier>
    </item>
    <item>
      <title>Activity-dependent PI4P synthesis by PI4KIIIα regulates long-term synaptic potentiation</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35235793/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Phosphatidylinositol 4-phosphate (PI4P) is a low abundant phospholipid with important roles in lipid transport and membrane trafficking. However, little is known of its metabolism and function in neurons. Here, we investigate its subcellular distribution and functional roles in dendrites of rodent hippocampal neurons during resting state and long-term synaptic potentiation (LTP). We show that neural activity causes dynamic reversible changes in PI4P metabolism in dendrites. Upon LTP induction,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Cell Rep. 2022 Mar 1;38(9):110452. doi: 10.1016/j.celrep.2022.110452.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Phosphatidylinositol 4-phosphate (PI4P) is a low abundant phospholipid with important roles in lipid transport and membrane trafficking. However, little is known of its metabolism and function in neurons. Here, we investigate its subcellular distribution and functional roles in dendrites of rodent hippocampal neurons during resting state and long-term synaptic potentiation (LTP). We show that neural activity causes dynamic reversible changes in PI4P metabolism in dendrites. Upon LTP induction, PI4KIIIα, a type III phosphatidylinositol 4-kinase, localizes to the dendritic plasma membrane (PM) in a calcium-dependent manner and causes substantial increase in the levels of PI4P. Acute inhibition of PI4KIIIα activity abolishes trafficking of the AMPA-type glutamate receptor to the PM during LTP induction, and silencing of PI4KIIIα expression in the hippocampal CA1 region causes severe impairment of LTP and long-term memory. Collectively, our results identify an essential role for PI4KIIIα-dependent PI4P synthesis in synaptic plasticity of central nervous system neurons.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35235793/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">35235793</a> | DOI:<a href=https://doi.org/10.1016/j.celrep.2022.110452>10.1016/j.celrep.2022.110452</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35235793</guid>
      <pubDate>Wed, 02 Mar 2022 06:00:00 -0500</pubDate>
      <dc:creator>Zhenzhen Guo</dc:creator>
      <dc:creator>Chao-Hua Jiang</dc:creator>
      <dc:creator>Chunfang Tong</dc:creator>
      <dc:creator>Yanrui Yang</dc:creator>
      <dc:creator>Zehua Wang</dc:creator>
      <dc:creator>Sin Man Lam</dc:creator>
      <dc:creator>Dou Wang</dc:creator>
      <dc:creator>Rui Li</dc:creator>
      <dc:creator>Guanghou Shui</dc:creator>
      <dc:creator>Yun Stone Shi</dc:creator>
      <dc:creator>Jia-Jia Liu</dc:creator>
      <dc:date>2022-03-02</dc:date>
      <dc:source>Cell reports</dc:source>
      <dc:title>Activity-dependent PI4P synthesis by PI4KIIIα regulates long-term synaptic potentiation</dc:title>
      <dc:identifier>pmid:35235793</dc:identifier>
      <dc:identifier>doi:10.1016/j.celrep.2022.110452</dc:identifier>
    </item>
    <item>
      <title>The complexin C-terminal amphipathic helix stabilizes the fusion pore open state by sculpting membranes</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/35132256/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Neurotransmitter release is mediated by proteins that drive synaptic vesicle fusion with the presynaptic plasma membrane. While soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs) form the core of the fusion apparatus, additional proteins play key roles in the fusion pathway. Here, we report that the C-terminal amphipathic helix of the mammalian accessory protein, complexin (Cpx), exerts profound effects on membranes, including the formation of pores and the efficient...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Struct Mol Biol. 2022 Feb;29(2):97-107. doi: 10.1038/s41594-021-00716-0. Epub 2022 Feb 7.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neurotransmitter release is mediated by proteins that drive synaptic vesicle fusion with the presynaptic plasma membrane. While soluble N-ethylmaleimide sensitive factor attachment protein receptors (SNAREs) form the core of the fusion apparatus, additional proteins play key roles in the fusion pathway. Here, we report that the C-terminal amphipathic helix of the mammalian accessory protein, complexin (Cpx), exerts profound effects on membranes, including the formation of pores and the efficient budding and fission of vesicles. Using nanodisc-black lipid membrane electrophysiology, we demonstrate that the membrane remodeling activity of Cpx modulates the structure and stability of recombinant exocytic fusion pores. Cpx had particularly strong effects on pores formed by small numbers of SNAREs. Under these conditions, Cpx increased the current through individual pores 3.5-fold, and increased the open time fraction from roughly 0.1 to 1.0. We propose that the membrane sculpting activity of Cpx contributes to the phospholipid rearrangements that underlie fusion by stabilizing highly curved membrane fusion intermediates.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/35132256/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">35132256</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8857072/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8857072</a> | DOI:<a href=https://doi.org/10.1038/s41594-021-00716-0>10.1038/s41594-021-00716-0</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:35132256</guid>
      <pubDate>Tue, 08 Feb 2022 06:00:00 -0500</pubDate>
      <dc:creator>Kevin C Courtney</dc:creator>
      <dc:creator>Lanxi Wu</dc:creator>
      <dc:creator>Taraknath Mandal</dc:creator>
      <dc:creator>Mark Swift</dc:creator>
      <dc:creator>Zhao Zhang</dc:creator>
      <dc:creator>Mohammad Alaghemandi</dc:creator>
      <dc:creator>Zhenyong Wu</dc:creator>
      <dc:creator>Mazdak M Bradberry</dc:creator>
      <dc:creator>Claire Deo</dc:creator>
      <dc:creator>Luke D Lavis</dc:creator>
      <dc:creator>Niels Volkmann</dc:creator>
      <dc:creator>Dorit Hanein</dc:creator>
      <dc:creator>Qiang Cui</dc:creator>
      <dc:creator>Huan Bao</dc:creator>
      <dc:creator>Edwin R Chapman</dc:creator>
      <dc:date>2022-02-08</dc:date>
      <dc:source>Nature structural &amp; molecular biology</dc:source>
      <dc:title>The complexin C-terminal amphipathic helix stabilizes the fusion pore open state by sculpting membranes</dc:title>
      <dc:identifier>pmid:35132256</dc:identifier>
      <dc:identifier>pmc:PMC8857072</dc:identifier>
      <dc:identifier>doi:10.1038/s41594-021-00716-0</dc:identifier>
    </item>
    <item>
      <title>Histology, Axon</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32119275/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>In 1860, the German anatomist Otto Friedrich Karl Deiters (1834-1863) described the basic structure of the nerve cell and identified two different protoplasmatic protrusions of the cell body that he termed as "axis cylinder," and "protoplasmatic processes," respectively axons and dendrites. Axons are the elongated portion of the neuron located in the center of the cell between the soma and axon terminals. In size, the axon may represent over 95% of the total volume of the neuron. Functionally,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">2021 Nov 19. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In 1860, the German anatomist Otto Friedrich Karl Deiters (1834-1863) described the basic structure of the nerve cell and identified two different protoplasmatic protrusions of the cell body that he termed as "axis cylinder," and "protoplasmatic processes," respectively axons and dendrites. Axons are the elongated portion of the neuron located in the center of the cell between the soma and axon terminals. In size, the axon may represent over 95% of the total volume of the neuron. Functionally, it carries electrical impulses and projects to synapses with dendrites or cell bodies of other neurons or with non-neuronal targets such as muscle fibers.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Concerning length, the length of axons varies according to the function of the neuron. Considering the functional distinction between projection neurons and interneurons, cortical projection neurons (CPNs), also termed as pyramidal neurons and spinal cord projection neurons (dorsal horn neurons), usually have long axons (from several mm and up to 1 m). In contrast, interneurons, that work within local circuits, have a short axonal terminal (up to several mm). The longest axons of the human body are those that make up the sciatic nerve where the length can exceed one meter. Furthermore, compared to projecting neurons, interneurons usually have smaller soma, fewer organelles, and a reduced amount of cytoplasm (axoplasm).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Histological observation of axon shows a cylindrical structure, but recent 3D electron microscopy studies demonstrated that probably axon has not the shape of a perfect cylinder. The diameter is variable as it ranges between 1 and 25 micrometers. In squid, it reaches a diameter of 1 mm. The variation of the diameter has important functional implications since the speed of propagation of the impulse (i.e., action potential), besides being dependent on the presence of the myelin sheath, is directly proportional to the diameter of the axon. Moreover, they have demonstrated significant changes in the diameter along the single axon.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The axon is one of two types of protoplasmic protrusions of the neuronal soma. The other protrusion is the dendrites. Axons are distinguished from dendrites by several characteristics including:</p><ol xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one" style="list-style-type:disc"><li><p><i>Shape</i>. Dendrites are usually thin while axons typically maintain a constant radius</p></li><li><p><i>Length</i>. Dendrites are limited to a small region around the cell body while axons can be much longer</p></li><li><p><i>Structure</i>. Substantial structural differences exist between dendrites and axons. For example, only dendrites contain rough endoplasmic reticulum and ribosomes, and the structure of the cytoskeleton is different. Differences also affect the membrane as it contains mostly voltage-gated ion channels in axons, whereas ligand-gated ion channels are present, especially in dendrites.</p></li><li><p><i>Functions</i>. Dendrites usually receive signals, while axons typically transmit them. However, all these rules have exceptions. Furthermore, axons generate and transmit all-or-none action potential, whereas dendrites produce depolarizing (below the threshold of the action potential) or hyperpolarizing (lowering the resting membrane potential) graded potentials.</p></li></ol><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Of note, although each neuron has only one axon, bifurcations that are branches of the main axon can be present. A collateral branch is an axonal protrusion over10 micrometers in length. These collaterals provide modulation and regulation of the cell firing pattern and represent a feedback system for the neuronal activity. The terminal part of the axon and collaterals tapers progressively. These parts are called telodendron and continue with the synapse (synaptic knob or button) which represents the specialized structure that comes into contact with another neuron (soma, axon or dendrite), or muscle fiber. Axon extension and growth of new telodendrons (and synapses) are guided by several factors, including the nerve growth factor (NGF). The branching processes, in turn, play a role of fundamental importance in neuroplasticity, for instance, in cognitive processes such as memory and learning.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Anatomically and based on the appearance of the protoplasmatic protrusions, neurons are classified into three groups:</p><ol xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one" style="list-style-type:disc"><li><p><i>Multipolar neurons.</i> They are the most common neurons; Shape: a single axon and many dendrites extending from the cell body. Localization: central nervous system (CNS)</p></li><li><p><i>Unipolar (or pseudounipolar) neurons.</i> Shape: a single short process that extends from the cell body and then splits into two branches in opposite directions; one branch travels to the peripheral nervous system (PNS) for the sensory reception, and the other to the CNS (central process). These neurons have no dendrites as the branched axon serving both functions. Localization: dorsal root ganglion and sensory ganglia of cranes nerves, and some mesencephalic nucleus</p></li><li><p><i> Bipolar neurons.</i> Shape: one axon and one dendrite that extend from the cell body in opposite directions. Localization: retinal cells and olfactory system</p></li></ol><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Two notable features distinguish the axon from the soma (also referred to as perikaryon). First, no rough endoplasmic reticulum extends into the axon; secondly, the composition of the axonic membrane (axolemma) is fundamentally different from that of the somatic membrane. These structural differences translate into functional distinctions. In fact, since the absence of ribosomes does not allow protein synthesis, all axon proteins originate in the soma. Furthermore, the particular structure of the membrane due to the presence of specific protein channels allows information to travel along the course of the axon. Again, depending on the location within the body, these structures can be covered in sheaths of an insulating material known as myelin. Based on the presence or absence of the myelin sheath, axons are distinguishable into myelinated and non-myelinated axons. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> <b>Myelin sheath</b> </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Myelin forms by the concentric wraps of the plasma membrane of neuroglia cells around the axon. These cells are the Schwann cells (or neurolemmocytes) in the PNS and oligodendrocytes in the CNS. As a general rule, oligodendrocytes myelinate multiple adjacent axons, while Schwann cells myelinate only one axon. In structural terms, the myelin sheath wraps the axons discontinuously as it is interrupted at regular intervals called Ranvier nodes (also termed as myelin sheath gaps), which represent the space between two consecutive Schwann cells and at which the axon is devoid of the sheath. In this way, employing the jump mechanism from one Ranvier node to the next, the propagation of the electrical signal is much faster than in the myelin sheathed axons. The cell membrane of Schwann cells is arranged around the axon, forming a double membrane structure (mesaxon), which elongates and wraps itself in a spiral, in concentric layers, around the axon itself. During this winding process, the cytoplasm of the Schwann cell is pushed towards the outside, while the surfaces of the contact membranes end up condensing, forming the lamellae of the myelin sheath. When the myelin sheath wraps around the axon, the mesaxon disappears by fusion of the cytoplasmic membranes in contact, except in correspondence with the innermost gyrus (internal mesaxon) and the outermost gyrus (external mesaxon or neurilemma) where there is a turn outermost rich in the cytoplasm. When the myelin sheath forms by oligodendrocytes (in PNS), the outermost gyrus reduces to a tongue and, in turn, although there is the internal mesaxon, the external one is not recognizable. Functionally, myelin represents an electrical insulator, allowing an increased speed of conduction along with an axon. It facilitates electrical transmission via saltatory conduction. Structurally, myelin is composed of approximately 80% of lipids (mostly cholesterol and variable amounts of cerebrosides and phospholipids) and 20% of proteins. However, depending on its location, myelin has a different composition as CNS myelin has more glycolipid and less phospholipid than PNS myelin.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32119275/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32119275</a> | Bookshelf:<a href="https://www.ncbi.nlm.nih.gov/books/NBK554388/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">NBK554388</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32119275</guid>
      <pubDate>Sat, 01 Jan 2022 06:00:00 -0500</pubDate>
      <dc:creator>Maria Rosaria Muzio</dc:creator>
      <dc:creator>Marco Cascella</dc:creator>
      <dc:date>2022-01</dc:date>
      <dc:source>StatPearls</dc:source>
      <dc:title>Histology, Axon</dc:title>
      <dc:identifier>pmid:32119275</dc:identifier>
      <dc:identifier>nbk:NBK554388</dc:identifier>
    </item>
    <item>
      <title>Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34819604/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The balances between NSCs growth and differentiation, and between glial and neuronal differentiation play a key role in brain regeneration after any pathological conditions. It is well known that the nervous tissue shows a poor recovery after injury due to the factors present in the wounded microenvironment, particularly inflammatory factors, that prevent neuronal differentiation. Thus, it is essential to generate a favourable condition for NSCs and conduct them to differentiate towards...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Sci Rep. 2021 Nov 24;11(1):22891. doi: 10.1038/s41598-021-02361-5.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The balances between NSCs growth and differentiation, and between glial and neuronal differentiation play a key role in brain regeneration after any pathological conditions. It is well known that the nervous tissue shows a poor recovery after injury due to the factors present in the wounded microenvironment, particularly inflammatory factors, that prevent neuronal differentiation. Thus, it is essential to generate a favourable condition for NSCs and conduct them to differentiate towards functional neurons. Here, we show that neuroinflammation has no effect on NSCs proliferation but induces an aberrant neuronal differentiation that gives rise to dystrophic, non-functional neurons. This is perhaps the initial step of brain failure associated to many neurological disorders. Interestingly, we demonstrate that phosphatidylcholine (PtdCho)-enriched media enhances neuronal differentiation even under inflammatory stress by modifying the commitment of post-mitotic cells. The pro-neurogenic effect of PtdCho increases the population of healthy normal neurons. In addition, we provide evidences that this phospholipid ameliorates the damage of neurons and, in consequence, modulates neuronal plasticity. These results contribute to our understanding of NSCs behaviour under inflammatory conditions, opening up new venues to improve neurogenic capacity in the brain.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34819604/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34819604</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8613233/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8613233</a> | DOI:<a href=https://doi.org/10.1038/s41598-021-02361-5>10.1038/s41598-021-02361-5</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34819604</guid>
      <pubDate>Thu, 25 Nov 2021 06:00:00 -0500</pubDate>
      <dc:creator>Dario Magaquian</dc:creator>
      <dc:creator>Susana Delgado Ocaña</dc:creator>
      <dc:creator>Consuelo Perez</dc:creator>
      <dc:creator>Claudia Banchio</dc:creator>
      <dc:date>2021-11-25</dc:date>
      <dc:source>Scientific reports</dc:source>
      <dc:title>Phosphatidylcholine restores neuronal plasticity of neural stem cells under inflammatory stress</dc:title>
      <dc:identifier>pmid:34819604</dc:identifier>
      <dc:identifier>pmc:PMC8613233</dc:identifier>
      <dc:identifier>doi:10.1038/s41598-021-02361-5</dc:identifier>
    </item>
    <item>
      <title>Synaptotagmin 1 oligomerization via the juxtamembrane linker regulates spontaneous and evoked neurotransmitter release</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34810248/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synaptotagmin 1 (syt1) is a Ca^(2+) sensor that regulates synaptic vesicle exocytosis. Cell-based experiments suggest that syt1 functions as a multimer; however, biochemical and electron microscopy studies have yielded contradictory findings regarding putative self-association. Here, we performed dynamic light scattering on syt1 in solution, followed by electron microscopy, and we used atomic force microscopy to study syt1 self-association on supported lipid bilayers under aqueous conditions....</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Proc Natl Acad Sci U S A. 2021 Nov 30;118(48):e2113859118. doi: 10.1073/pnas.2113859118.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synaptotagmin 1 (syt1) is a Ca<sup>2+</sup> sensor that regulates synaptic vesicle exocytosis. Cell-based experiments suggest that syt1 functions as a multimer; however, biochemical and electron microscopy studies have yielded contradictory findings regarding putative self-association. Here, we performed dynamic light scattering on syt1 in solution, followed by electron microscopy, and we used atomic force microscopy to study syt1 self-association on supported lipid bilayers under aqueous conditions. Ring-like multimers were clearly observed. Multimerization was enhanced by Ca<sup>2+</sup> and required anionic phospholipids. Large ring-like structures (∼180 nm) were reduced to smaller rings (∼30 nm) upon neutralization of a cluster of juxtamembrane lysine residues; further substitution of residues in the second C2-domain completely abolished self-association. When expressed in neurons, syt1 mutants with graded reductions in self-association activity exhibited concomitant reductions in 1) clamping spontaneous release and 2) triggering and synchronizing evoked release. Thus, the juxtamembrane linker of syt1 plays a crucial role in exocytosis by mediating multimerization.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34810248/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34810248</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8694047/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8694047</a> | DOI:<a href=https://doi.org/10.1073/pnas.2113859118>10.1073/pnas.2113859118</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34810248</guid>
      <pubDate>Tue, 23 Nov 2021 06:00:00 -0500</pubDate>
      <dc:creator>Kevin C Courtney</dc:creator>
      <dc:creator>Jason D Vevea</dc:creator>
      <dc:creator>Yueqi Li</dc:creator>
      <dc:creator>Zhenyong Wu</dc:creator>
      <dc:creator>Zhao Zhang</dc:creator>
      <dc:creator>Edwin R Chapman</dc:creator>
      <dc:date>2021-11-23</dc:date>
      <dc:source>Proceedings of the National Academy of Sciences of the United States of America</dc:source>
      <dc:title>Synaptotagmin 1 oligomerization via the juxtamembrane linker regulates spontaneous and evoked neurotransmitter release</dc:title>
      <dc:identifier>pmid:34810248</dc:identifier>
      <dc:identifier>pmc:PMC8694047</dc:identifier>
      <dc:identifier>doi:10.1073/pnas.2113859118</dc:identifier>
    </item>
    <item>
      <title>Cryo-EM structure of human GPR158 receptor coupled to the RGS7-Gβ5 signaling complex</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34793198/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>GPR158 is an orphan G protein–coupled receptor (GPCR) highly expressed in the brain, where it controls synapse formation and function. GPR158 has also been implicated in depression, carcinogenesis, and cognition. However, the structural organization and signaling mechanisms of GPR158 are largely unknown. We used single-particle cryo–electron microscopy (cryo-EM) to determine the structures of human GPR158 alone and bound to an RGS signaling complex. The structures reveal a homodimeric...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Science. 2022 Jan 7;375(6576):86-91. doi: 10.1126/science.abl4732. Epub 2021 Nov 18.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">GPR158 is an orphan G protein–coupled receptor (GPCR) highly expressed in the brain, where it controls synapse formation and function. GPR158 has also been implicated in depression, carcinogenesis, and cognition. However, the structural organization and signaling mechanisms of GPR158 are largely unknown. We used single-particle cryo–electron microscopy (cryo-EM) to determine the structures of human GPR158 alone and bound to an RGS signaling complex. The structures reveal a homodimeric organization stabilized by a pair of phospholipids and the presence of an extracellular Cache domain, an unusual ligand-binding domain in GPCRs. We further demonstrate the structural basis of GPR158 coupling to RGS7-Gβ5. Together, these results provide insights into the unusual biology of orphan receptors and the formation of GPCR-RGS complexes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34793198/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34793198</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8926151/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8926151</a> | DOI:<a href=https://doi.org/10.1126/science.abl4732>10.1126/science.abl4732</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34793198</guid>
      <pubDate>Thu, 18 Nov 2021 06:00:00 -0500</pubDate>
      <dc:creator>Dipak N Patil</dc:creator>
      <dc:creator>Shikha Singh</dc:creator>
      <dc:creator>Thibaut Laboute</dc:creator>
      <dc:creator>Timothy S Strutzenberg</dc:creator>
      <dc:creator>Xingyu Qiu</dc:creator>
      <dc:creator>Di Wu</dc:creator>
      <dc:creator>Scott J Novick</dc:creator>
      <dc:creator>Carol V Robinson</dc:creator>
      <dc:creator>Patrick R Griffin</dc:creator>
      <dc:creator>John F Hunt</dc:creator>
      <dc:creator>Tina Izard</dc:creator>
      <dc:creator>Appu K Singh</dc:creator>
      <dc:creator>Kirill A Martemyanov</dc:creator>
      <dc:date>2021-11-18</dc:date>
      <dc:source>Science (New York, N.Y.)</dc:source>
      <dc:title>Cryo-EM structure of human GPR158 receptor coupled to the RGS7-Gβ5 signaling complex</dc:title>
      <dc:identifier>pmid:34793198</dc:identifier>
      <dc:identifier>pmc:PMC8926151</dc:identifier>
      <dc:identifier>doi:10.1126/science.abl4732</dc:identifier>
    </item>
    <item>
      <title>Drosophila ß&lt;sub&gt;Heavy&lt;/sub&gt;-Spectrin is required in polarized ensheathing glia that form a diffusion-barrier around the neuropil</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34737284/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>In the central nervous system (CNS), functional tasks are often allocated to distinct compartments. This is also evident in the Drosophila CNS where synapses and dendrites are clustered in distinct neuropil regions. The neuropil is separated from neuronal cell bodies by ensheathing glia, which as we show using dye injection experiments, contribute to the formation of an internal diffusion barrier. We find that ensheathing glia are polarized with a basolateral plasma membrane rich in...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Commun. 2021 Nov 4;12(1):6357. doi: 10.1038/s41467-021-26462-x.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In the central nervous system (CNS), functional tasks are often allocated to distinct compartments. This is also evident in the Drosophila CNS where synapses and dendrites are clustered in distinct neuropil regions. The neuropil is separated from neuronal cell bodies by ensheathing glia, which as we show using dye injection experiments, contribute to the formation of an internal diffusion barrier. We find that ensheathing glia are polarized with a basolateral plasma membrane rich in phosphatidylinositol-(3,4,5)-triphosphate (PIP<sub>3</sub>) and the Na<sup>+</sup>/K<sup>+</sup>-ATPase Nervana2 (Nrv2) that abuts an extracellular matrix formed at neuropil-cortex interface. The apical plasma membrane is facing the neuropil and is rich in phosphatidylinositol-(4,5)-bisphosphate (PIP<sub>2</sub>) that is supported by a sub-membranous ß<sub>Heavy</sub>-Spectrin cytoskeleton. ß<sub>Heavy</sub>-spectrin mutant larvae affect ensheathing glial cell polarity with delocalized PIP<sub>2</sub> and Nrv2 and exhibit an abnormal locomotion which is similarly shown by ensheathing glia ablated larvae. Thus, polarized glia compartmentalizes the brain and is essential for proper nervous system function.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34737284/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34737284</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8569210/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8569210</a> | DOI:<a href=https://doi.org/10.1038/s41467-021-26462-x>10.1038/s41467-021-26462-x</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34737284</guid>
      <pubDate>Fri, 05 Nov 2021 06:00:00 -0400</pubDate>
      <dc:creator>Nicole Pogodalla</dc:creator>
      <dc:creator>Holger Kranenburg</dc:creator>
      <dc:creator>Simone Rey</dc:creator>
      <dc:creator>Silke Rodrigues</dc:creator>
      <dc:creator>Albert Cardona</dc:creator>
      <dc:creator>Christian Klämbt</dc:creator>
      <dc:date>2021-11-05</dc:date>
      <dc:source>Nature communications</dc:source>
      <dc:title>Drosophila ß&lt;sub&gt;Heavy&lt;/sub&gt;-Spectrin is required in polarized ensheathing glia that form a diffusion-barrier around the neuropil</dc:title>
      <dc:identifier>pmid:34737284</dc:identifier>
      <dc:identifier>pmc:PMC8569210</dc:identifier>
      <dc:identifier>doi:10.1038/s41467-021-26462-x</dc:identifier>
    </item>
    <item>
      <title>Munc13-1 is a Ca&lt;sup&gt;2+&lt;/sup&gt;-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34706220/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>During ongoing presynaptic action potential (AP) firing, transmitter release is limited by the availability of release-ready synaptic vesicles (SVs). The rate of SV recruitment (SVR) to release sites is strongly upregulated at high AP frequencies to balance SV consumption. We show that Munc13-1-an essential SV priming protein-regulates SVR via a Ca^(2+)-phospholipid-dependent mechanism. Using knockin mouse lines with point mutations in the Ca^(2+)-phospholipid-binding C(2)B domain of Munc13-1,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Neuron. 2021 Dec 15;109(24):3980-4000.e7. doi: 10.1016/j.neuron.2021.09.054. Epub 2021 Oct 26.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">During ongoing presynaptic action potential (AP) firing, transmitter release is limited by the availability of release-ready synaptic vesicles (SVs). The rate of SV recruitment (SVR) to release sites is strongly upregulated at high AP frequencies to balance SV consumption. We show that Munc13-1-an essential SV priming protein-regulates SVR via a Ca<sup>2+</sup>-phospholipid-dependent mechanism. Using knockin mouse lines with point mutations in the Ca<sup>2+</sup>-phospholipid-binding C<sub>2</sub>B domain of Munc13-1, we demonstrate that abolishing Ca<sup>2+</sup>-phospholipid binding increases synaptic depression, slows recovery of synaptic strength after SV pool depletion, and reduces temporal fidelity of synaptic transmission, while increased Ca<sup>2+</sup>-phospholipid binding has the opposite effects. Thus, Ca<sup>2+</sup>-phospholipid binding to the Munc13-1-C<sub>2</sub>B domain accelerates SVR, reduces short-term synaptic depression, and increases the endurance and temporal fidelity of neurotransmission, demonstrating that Munc13-1 is a core vesicle priming hub that adjusts SV re-supply to demand.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34706220/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34706220</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8691950/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8691950</a> | DOI:<a href=https://doi.org/10.1016/j.neuron.2021.09.054>10.1016/j.neuron.2021.09.054</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34706220</guid>
      <pubDate>Wed, 27 Oct 2021 06:00:00 -0400</pubDate>
      <dc:creator>Noa Lipstein</dc:creator>
      <dc:creator>Shuwen Chang</dc:creator>
      <dc:creator>Kun-Han Lin</dc:creator>
      <dc:creator>Francisco José López-Murcia</dc:creator>
      <dc:creator>Erwin Neher</dc:creator>
      <dc:creator>Holger Taschenberger</dc:creator>
      <dc:creator>Nils Brose</dc:creator>
      <dc:date>2021-10-27</dc:date>
      <dc:source>Neuron</dc:source>
      <dc:title>Munc13-1 is a Ca&lt;sup&gt;2+&lt;/sup&gt;-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission</dc:title>
      <dc:identifier>pmid:34706220</dc:identifier>
      <dc:identifier>pmc:PMC8691950</dc:identifier>
      <dc:identifier>doi:10.1016/j.neuron.2021.09.054</dc:identifier>
    </item>
    <item>
      <title>Phospholipid-flippase chaperone CDC50A is required for synapse maintenance by regulating phosphatidylserine exposure</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34585770/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synaptic refinement is a critical physiological process that removes excess synapses to establish and maintain functional neuronal circuits. Recent studies have shown that focal exposure of phosphatidylserine (PS) on synapses acts as an "eat me" signal to mediate synaptic pruning. However, the molecular mechanism underlying PS externalization at synapses remains elusive. Here, we find that murine CDC50A, a chaperone of phospholipid flippases, localizes to synapses, and that its expression...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2021 Nov 2;40(21):e107915. doi: 10.15252/embj.2021107915. Epub 2021 Sep 29.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synaptic refinement is a critical physiological process that removes excess synapses to establish and maintain functional neuronal circuits. Recent studies have shown that focal exposure of phosphatidylserine (PS) on synapses acts as an "eat me" signal to mediate synaptic pruning. However, the molecular mechanism underlying PS externalization at synapses remains elusive. Here, we find that murine CDC50A, a chaperone of phospholipid flippases, localizes to synapses, and that its expression depends on neuronal activity. Cdc50a knockdown leads to phosphatidylserine exposure at synapses and subsequent erroneous synapse removal by microglia partly via the GPR56 pathway. Taken together, our data support that CDC50A safeguards synapse maintenance by regulating focal phosphatidylserine exposure at synapses.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34585770/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34585770</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8561630/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8561630</a> | DOI:<a href=https://doi.org/10.15252/embj.2021107915>10.15252/embj.2021107915</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34585770</guid>
      <pubDate>Wed, 29 Sep 2021 06:00:00 -0400</pubDate>
      <dc:creator>Tao Li</dc:creator>
      <dc:creator>Diankun Yu</dc:creator>
      <dc:creator>Hayeon C Oak</dc:creator>
      <dc:creator>Beika Zhu</dc:creator>
      <dc:creator>Li Wang</dc:creator>
      <dc:creator>Xueqiao Jiang</dc:creator>
      <dc:creator>Robert S Molday</dc:creator>
      <dc:creator>Arnold Kriegstein</dc:creator>
      <dc:creator>Xianhua Piao</dc:creator>
      <dc:date>2021-09-29</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>Phospholipid-flippase chaperone CDC50A is required for synapse maintenance by regulating phosphatidylserine exposure</dc:title>
      <dc:identifier>pmid:34585770</dc:identifier>
      <dc:identifier>pmc:PMC8561630</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2021107915</dc:identifier>
    </item>
    <item>
      <title>Expression and distribution of synaptotagmin family members in the zebrafish retina</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34468021/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synaptotagmins belong to a large family of proteins. Although various synaptotagmins have been implicated as Ca^(2+) sensors for vesicle replenishment and release at conventional synapses, their roles at retinal ribbon synapses remain incompletely understood. Zebrafish is a widely used experimental model for retinal research. We therefore investigated the homology between human, rat, mouse, and zebrafish synaptotagmins 1-10 using a bioinformatics approach. We also characterized the expression...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Comp Neurol. 2022 Mar;530(4):705-728. doi: 10.1002/cne.25238. Epub 2021 Sep 24.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synaptotagmins belong to a large family of proteins. Although various synaptotagmins have been implicated as Ca<sup>2+</sup> sensors for vesicle replenishment and release at conventional synapses, their roles at retinal ribbon synapses remain incompletely understood. Zebrafish is a widely used experimental model for retinal research. We therefore investigated the homology between human, rat, mouse, and zebrafish synaptotagmins 1-10 using a bioinformatics approach. We also characterized the expression and distribution of various synaptotagmin (syt) genes in the zebrafish retina using RT-PCR, qPCR, and in situhybridization, focusing on the family members whose products likely underlie Ca<sup>2+</sup> -dependent exocytosis in the central nervous system (synaptotagmins 1, 2, 5, and 7). Most zebrafish synaptotagmins are well conserved and can be grouped in the same classes as mammalian synaptotagmins, based on crucial amino acid residues needed for coordinating Ca<sup>2+</sup> binding and determining phospholipid binding affinity. The only exception is synaptotagmin 1b, which lacks 34 amino acid residues in the C2B domain and is therefore unlikely to bind Ca<sup>2+</sup> there. Additionally, the products of zebrafish syt5a and syt5b genes share identity with mammalian class 1 and 5 synaptotagmins. Zebrafish syt1, syt2, syt5, and syt7 paralogues are found in the zebrafish brain, eye, and retina, excepting syt1b, which is only present in the brain. The complementary expression pattern of the remaining paralogues in the retina suggests that syt1a and syt5a may underlie synchronous release and syt7a and syt7b may mediate asynchronous release or other Ca<sup>2+</sup> -dependent processes in different retinal neurons.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34468021/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34468021</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8792163/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8792163</a> | DOI:<a href=https://doi.org/10.1002/cne.25238>10.1002/cne.25238</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34468021</guid>
      <pubDate>Wed, 01 Sep 2021 06:00:00 -0400</pubDate>
      <dc:creator>Diane Henry</dc:creator>
      <dc:creator>Christina Joselevitch</dc:creator>
      <dc:creator>Gary G Matthews</dc:creator>
      <dc:creator>Lonnie P Wollmuth</dc:creator>
      <dc:date>2021-09-01</dc:date>
      <dc:source>The Journal of comparative neurology</dc:source>
      <dc:title>Expression and distribution of synaptotagmin family members in the zebrafish retina</dc:title>
      <dc:identifier>pmid:34468021</dc:identifier>
      <dc:identifier>pmc:PMC8792163</dc:identifier>
      <dc:identifier>doi:10.1002/cne.25238</dc:identifier>
    </item>
    <item>
      <title>The Phagocytic Code Regulating Phagocytosis of Mammalian Cells</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34177884/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Mammalian phagocytes can phagocytose (i.e. eat) other mammalian cells in the body if they display certain signals, and this phagocytosis plays fundamental roles in development, cell turnover, tissue homeostasis and disease prevention. To phagocytose the correct cells, phagocytes must discriminate which cells to eat using a 'phagocytic code' - a set of over 50 known phagocytic signals determining whether a cell is eaten or not - comprising find-me signals, eat-me signals, don't-eat-me signals and...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Front Immunol. 2021 Jun 9;12:629979. doi: 10.3389/fimmu.2021.629979. eCollection 2021.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mammalian phagocytes can phagocytose (i.e. eat) other mammalian cells in the body if they display certain signals, and this phagocytosis plays fundamental roles in development, cell turnover, tissue homeostasis and disease prevention. To phagocytose the correct cells, phagocytes must discriminate which cells to eat using a 'phagocytic code' - a set of over 50 known phagocytic signals determining whether a cell is eaten or not - comprising find-me signals, eat-me signals, don't-eat-me signals and opsonins. Most opsonins require binding to eat-me signals - for example, the opsonins galectin-3, calreticulin and C1q bind asialoglycan eat-me signals on target cells - to induce phagocytosis. Some proteins act as 'self-opsonins', while others are 'negative opsonins' or 'phagocyte suppressants', inhibiting phagocytosis. We review known phagocytic signals here, both established and novel, and how they integrate to regulate phagocytosis of several mammalian targets - including excess cells in development, senescent and aged cells, infected cells, cancer cells, dead or dying cells, cell debris and neuronal synapses. Understanding the phagocytic code, and how it goes wrong, may enable novel therapies for multiple pathologies with too much or too little phagocytosis, such as: infectious disease, cancer, neurodegeneration, psychiatric disease, cardiovascular disease, ageing and auto-immune disease.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34177884/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34177884</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8220072/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8220072</a> | DOI:<a href=https://doi.org/10.3389/fimmu.2021.629979>10.3389/fimmu.2021.629979</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34177884</guid>
      <pubDate>Mon, 28 Jun 2021 06:00:00 -0400</pubDate>
      <dc:creator>Tom O J Cockram</dc:creator>
      <dc:creator>Jacob M Dundee</dc:creator>
      <dc:creator>Alma S Popescu</dc:creator>
      <dc:creator>Guy C Brown</dc:creator>
      <dc:date>2021-06-28</dc:date>
      <dc:source>Frontiers in immunology</dc:source>
      <dc:title>The Phagocytic Code Regulating Phagocytosis of Mammalian Cells</dc:title>
      <dc:identifier>pmid:34177884</dc:identifier>
      <dc:identifier>pmc:PMC8220072</dc:identifier>
      <dc:identifier>doi:10.3389/fimmu.2021.629979</dc:identifier>
    </item>
    <item>
      <title>Utilizing magnetic resonance techniques to study membrane interactions of amyloid peptides</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34156433/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Alzheimer's disease (AD) is a common neurodegenerative condition that involves the extracellular accumulation of amyloid plaques predominantly consisting of Aβ peptide aggregates. The amyloid plaques and soluble oligomeric species of Aβ are believed to be the major cause of synaptic dysfunction in AD brain and their cytotoxic mechanisms have been proposed to involve interactions with cell membranes. In this review, we discuss our solid-state nuclear magnetic resonance (ssNMR) studies of Aβ...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Biochem Soc Trans. 2021 Jun 30;49(3):1457-1465. doi: 10.1042/BST20201244.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Alzheimer's disease (AD) is a common neurodegenerative condition that involves the extracellular accumulation of amyloid plaques predominantly consisting of Aβ peptide aggregates. The amyloid plaques and soluble oligomeric species of Aβ are believed to be the major cause of synaptic dysfunction in AD brain and their cytotoxic mechanisms have been proposed to involve interactions with cell membranes. In this review, we discuss our solid-state nuclear magnetic resonance (ssNMR) studies of Aβ interactions with model membranes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34156433/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34156433</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8286822/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8286822</a> | DOI:<a href=https://doi.org/10.1042/BST20201244>10.1042/BST20201244</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34156433</guid>
      <pubDate>Tue, 22 Jun 2021 06:00:00 -0400</pubDate>
      <dc:creator>Sunnia Rajput</dc:creator>
      <dc:creator>Marc-Antoine Sani</dc:creator>
      <dc:creator>David W Keizer</dc:creator>
      <dc:creator>Frances Separovic</dc:creator>
      <dc:date>2021-06-22</dc:date>
      <dc:source>Biochemical Society transactions</dc:source>
      <dc:title>Utilizing magnetic resonance techniques to study membrane interactions of amyloid peptides</dc:title>
      <dc:identifier>pmid:34156433</dc:identifier>
      <dc:identifier>pmc:PMC8286822</dc:identifier>
      <dc:identifier>doi:10.1042/BST20201244</dc:identifier>
    </item>
    <item>
      <title>Microglial MERTK eliminates phosphatidylserine-displaying inhibitory post-synapses</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34013588/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Glia contribute to synapse elimination through phagocytosis in the central nervous system. Despite the important roles of this process in development and neurological disorders, the identity and regulation of the "eat-me" signal that initiates glia-mediated phagocytosis of synapses has remained incompletely understood. Here, we generated conditional knockout mice with neuronal-specific deletion of the flippase chaperone Cdc50a, to induce stable exposure of phosphatidylserine, a well-known...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2021 Aug 2;40(15):e107121. doi: 10.15252/embj.2020107121. Epub 2021 May 19.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Glia contribute to synapse elimination through phagocytosis in the central nervous system. Despite the important roles of this process in development and neurological disorders, the identity and regulation of the "eat-me" signal that initiates glia-mediated phagocytosis of synapses has remained incompletely understood. Here, we generated conditional knockout mice with neuronal-specific deletion of the flippase chaperone Cdc50a, to induce stable exposure of phosphatidylserine, a well-known "eat-me" signal for apoptotic cells, on the neuronal outer membrane. Surprisingly, acute Cdc50a deletion in mature neurons causes preferential phosphatidylserine exposure in neuronal somas and specific loss of inhibitory post-synapses without effects on other synapses, resulting in abnormal excitability and seizures. Ablation of microglia or the deletion of microglial phagocytic receptor Mertk prevents the loss of inhibitory post-synapses and the seizure phenotype, indicating that microglial phagocytosis is responsible for inhibitory post-synapse elimination. Moreover, we found that phosphatidylserine is used for microglia-mediated pruning of inhibitory post-synapses in normal brains, suggesting that phosphatidylserine serves as a general "eat-me" signal for inhibitory post-synapse elimination.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34013588/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34013588</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8327958/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8327958</a> | DOI:<a href=https://doi.org/10.15252/embj.2020107121>10.15252/embj.2020107121</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34013588</guid>
      <pubDate>Thu, 20 May 2021 06:00:00 -0400</pubDate>
      <dc:creator>Jungjoo Park</dc:creator>
      <dc:creator>Yeeun Choi</dc:creator>
      <dc:creator>Eunji Jung</dc:creator>
      <dc:creator>Seung-Hee Lee</dc:creator>
      <dc:creator>Jong-Woo Sohn</dc:creator>
      <dc:creator>Won-Suk Chung</dc:creator>
      <dc:date>2021-05-20</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>Microglial MERTK eliminates phosphatidylserine-displaying inhibitory post-synapses</dc:title>
      <dc:identifier>pmid:34013588</dc:identifier>
      <dc:identifier>pmc:PMC8327958</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2020107121</dc:identifier>
    </item>
    <item>
      <title>LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/34006637/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The liver X receptor (LXR) is a key transcriptional regulator of cholesterol, fatty acid, and phospholipid metabolism. Dynamic remodeling of immunometabolic pathways, including lipid metabolism, is a crucial step in T cell activation. Here, we explored the role of LXR-regulated metabolic processes in primary human CD4^(+) T cells and their role in controlling plasma membrane lipids (glycosphingolipids and cholesterol), which strongly influence T cell immune signaling and function. Crucially, we...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Proc Natl Acad Sci U S A. 2021 May 25;118(21):e2017394118. doi: 10.1073/pnas.2017394118.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The liver X receptor (LXR) is a key transcriptional regulator of cholesterol, fatty acid, and phospholipid metabolism. Dynamic remodeling of immunometabolic pathways, including lipid metabolism, is a crucial step in T cell activation. Here, we explored the role of LXR-regulated metabolic processes in primary human CD4<sup>+</sup> T cells and their role in controlling plasma membrane lipids (glycosphingolipids and cholesterol), which strongly influence T cell immune signaling and function. Crucially, we identified the glycosphingolipid biosynthesis enzyme glucosylceramide synthase as a direct transcriptional LXR target. LXR activation by agonist GW3965 or endogenous oxysterol ligands significantly altered the glycosphingolipid:cholesterol balance in the plasma membrane by increasing glycosphingolipid levels and reducing cholesterol. Consequently, LXR activation lowered plasma membrane lipid order (stability), and an LXR antagonist could block this effect. LXR stimulation also reduced lipid order at the immune synapse and accelerated activation of proximal T cell signaling molecules. Ultimately, LXR activation dampened proinflammatory T cell function. Finally, compared with responder T cells, regulatory T cells had a distinct pattern of LXR target gene expression corresponding to reduced lipid order. This suggests LXR-driven lipid metabolism could contribute to functional specialization of these T cell subsets. Overall, we report a mode of action for LXR in T cells involving the regulation of glycosphingolipid and cholesterol metabolism and demonstrate its relevance in modulating T cell function.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/34006637/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">34006637</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8166169/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8166169</a> | DOI:<a href=https://doi.org/10.1073/pnas.2017394118>10.1073/pnas.2017394118</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:34006637</guid>
      <pubDate>Wed, 19 May 2021 06:00:00 -0400</pubDate>
      <dc:creator>Kirsty E Waddington</dc:creator>
      <dc:creator>George A Robinson</dc:creator>
      <dc:creator>Beatriz Rubio-Cuesta</dc:creator>
      <dc:creator>Eden Chrifi-Alaoui</dc:creator>
      <dc:creator>Sara Andreone</dc:creator>
      <dc:creator>Kok-Siong Poon</dc:creator>
      <dc:creator>Iveta Ivanova</dc:creator>
      <dc:creator>Lucia Martin-Gutierrez</dc:creator>
      <dc:creator>Dylan M Owen</dc:creator>
      <dc:creator>Elizabeth C Jury</dc:creator>
      <dc:creator>Inés Pineda-Torra</dc:creator>
      <dc:date>2021-05-19</dc:date>
      <dc:source>Proceedings of the National Academy of Sciences of the United States of America</dc:source>
      <dc:title>LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function</dc:title>
      <dc:identifier>pmid:34006637</dc:identifier>
      <dc:identifier>pmc:PMC8166169</dc:identifier>
      <dc:identifier>doi:10.1073/pnas.2017394118</dc:identifier>
    </item>
    <item>
      <title>Flexible pivoting of dynamin pleckstrin homology domain catalyzes fission: insights into molecular degrees of freedom</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33979205/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The neuronal dynamin1 functions in the release of synaptic vesicles by orchestrating the process of GTPase-dependent membrane fission. Dynamin1 associates with the plasma membrane-localized phosphatidylinositol-4,5-bisphosphate (PIP(2)) through the centrally located pleckstrin homology domain (PHD). The PHD is dispensable as fission (in model membranes) can be managed, even when the PHD-PIP(2) interaction is replaced by a generic polyhistidine- or polylysine-lipid interaction. However, the...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Mol Biol Cell. 2021 Jul 1;32(14):1306-1319. doi: 10.1091/mbc.E20-12-0794. Epub 2021 May 12.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The neuronal dynamin1 functions in the release of synaptic vesicles by orchestrating the process of GTPase-dependent membrane fission. Dynamin1 associates with the plasma membrane-localized phosphatidylinositol-4,5-bisphosphate (PIP<sub>2</sub>) through the centrally located pleckstrin homology domain (PHD). The PHD is dispensable as fission (in model membranes) can be managed, even when the PHD-PIP<sub>2</sub> interaction is replaced by a generic polyhistidine- or polylysine-lipid interaction. However, the absence of the PHD renders a dramatic dampening of the rate of fission. These observations suggest that the PHD-PIP<sub>2</sub>-containing membrane interaction could have evolved to expedite fission to fulfill the requirement of rapid kinetics of synaptic vesicle recycling. Here, we use a suite of multiscale modeling approaches to explore PHD-membrane interactions. Our results reveal that 1) the binding of PHD to PIP<sub>2</sub>-containing membranes modulates the lipids toward fission-favoring conformations and softens the membrane, and 2) PHD associates with membrane in multiple orientations using variable loops as pivots. We identify a new loop (VL4), which acts as an auxiliary pivot and modulates the orientation flexibility of PHD on the membrane-a mechanism that we believe may be important for high-fidelity dynamin collar assembly. Together, these insights provide a molecular-level understanding of the catalytic role of PHD in dynamin-mediated membrane fission.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33979205/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33979205</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8351549/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8351549</a> | DOI:<a href=https://doi.org/10.1091/mbc.E20-12-0794>10.1091/mbc.E20-12-0794</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33979205</guid>
      <pubDate>Wed, 12 May 2021 06:00:00 -0400</pubDate>
      <dc:creator>Krishnakanth Baratam</dc:creator>
      <dc:creator>Kirtika Jha</dc:creator>
      <dc:creator>Anand Srivastava</dc:creator>
      <dc:date>2021-05-12</dc:date>
      <dc:source>Molecular biology of the cell</dc:source>
      <dc:title>Flexible pivoting of dynamin pleckstrin homology domain catalyzes fission: insights into molecular degrees of freedom</dc:title>
      <dc:identifier>pmid:33979205</dc:identifier>
      <dc:identifier>pmc:PMC8351549</dc:identifier>
      <dc:identifier>doi:10.1091/mbc.E20-12-0794</dc:identifier>
    </item>
    <item>
      <title>Membrane morphology determines diacylglycerol kinase α substrate acyl chain specificity</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33977628/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Diacylglycerol kinases catalyze the ATP-dependent phosphorylation of diacylglycerol (DAG) to produce phosphatidic acid (PA). In humans, the alpha isoform (DGKα) has emerged as a potential target in the treatment of cancer due to its anti-tumor and pro-immune responses. However, its mechanism of action at a molecular level is not fully understood. In this work, a systematic investigation of the role played by the membrane in the regulation of the enzymatic properties of human DGKα is presented....</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">FASEB J. 2021 Jun;35(6):e21602. doi: 10.1096/fj.202100264R.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diacylglycerol kinases catalyze the ATP-dependent phosphorylation of diacylglycerol (DAG) to produce phosphatidic acid (PA). In humans, the alpha isoform (DGKα) has emerged as a potential target in the treatment of cancer due to its anti-tumor and pro-immune responses. However, its mechanism of action at a molecular level is not fully understood. In this work, a systematic investigation of the role played by the membrane in the regulation of the enzymatic properties of human DGKα is presented. By using a cell-free system with purified DGKα and model membranes of variable physical and chemical properties, it is shown that membrane physical properties determine human DGKα substrate acyl chain specificity. In model membranes with a flat morphology; DGKα presents high enzymatic activity, but it is not able to differentiate DAG molecular species. Furthermore, DGKα enzymatic properties are insensitive to membrane intrinsic curvature. However, in the presence of model membranes with altered morphology, specifically the presence of physically curved membrane structures, DGKα bears substrate acyl chain specificity for palmitic acid-containing DAG. The present results identify changes in membrane morphology as one possible mechanism for the depletion of specific pools of DAG as well as the production of specific pools of PA by DGKα, adding an extra layer of regulation on the interconversion of these two potent lipid-signaling molecules. It is proposed that the interplay between membrane physical (shape) and chemical (lipid composition) properties guarantee a fine-tuned signal transduction system dependent on the levels and molecular species of DAG and PA.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33977628/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33977628</a> | DOI:<a href=https://doi.org/10.1096/fj.202100264R>10.1096/fj.202100264R</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33977628</guid>
      <pubDate>Wed, 12 May 2021 06:00:00 -0400</pubDate>
      <dc:creator>José Carlos Bozelli</dc:creator>
      <dc:creator>Jenny Yune</dc:creator>
      <dc:creator>Daisuke Takahashi</dc:creator>
      <dc:creator>Fumio Sakane</dc:creator>
      <dc:creator>Richard M Epand</dc:creator>
      <dc:date>2021-05-12</dc:date>
      <dc:source>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</dc:source>
      <dc:title>Membrane morphology determines diacylglycerol kinase α substrate acyl chain specificity</dc:title>
      <dc:identifier>pmid:33977628</dc:identifier>
      <dc:identifier>doi:10.1096/fj.202100264R</dc:identifier>
    </item>
    <item>
      <title>Activation of V&lt;sub&gt;1a&lt;/sub&gt; vasopressin receptors excite subicular pyramidal neurons by activating TRPV1 and depressing GIRK channels</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33891950/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Arginine vasopressin (AVP) is a nonapeptide that serves as a neuromodulator in the brain and a hormone in the periphery that regulates water homeostasis and vasoconstriction. The subiculum is the major output region of the hippocampus and an integral component in the networks that processes sensory and motor cues to form a cognitive map encoding spatial, contextual, and emotional information. Whereas the subiculum expresses high densities of AVP-binding sites and AVP has been shown to increase...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Neuropharmacology. 2021 Jun 1;190:108565. doi: 10.1016/j.neuropharm.2021.108565. Epub 2021 Apr 20.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Arginine vasopressin (AVP) is a nonapeptide that serves as a neuromodulator in the brain and a hormone in the periphery that regulates water homeostasis and vasoconstriction. The subiculum is the major output region of the hippocampus and an integral component in the networks that processes sensory and motor cues to form a cognitive map encoding spatial, contextual, and emotional information. Whereas the subiculum expresses high densities of AVP-binding sites and AVP has been shown to increase the synaptic excitability of subicular pyramidal neurons, the underlying cellular and molecular mechanisms have not been determined. We found that activation of V<sub>1a</sub> receptors increased the excitability of subicular pyramidal neurons via activation of TRPV1 channels and depression of the GIRK channels. V<sub>1a</sub> receptor-induced excitation of subicular pyramidal neurons required the function of phospholipase Cβ, but was independent of intracellular Ca<sup>2+</sup> release. Protein kinase C was responsible for AVP-mediated depression of GIRK channels, whereas degradation of phosphatidylinositol 4,5-bisphosphate was involved in V<sub>1a</sub> receptor-elicited activation of TRPV1 channels. Our results may provide one of the cellular and molecular mechanisms to explain the physiological functions of AVP in the brain.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33891950/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33891950</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8169586/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8169586</a> | DOI:<a href=https://doi.org/10.1016/j.neuropharm.2021.108565>10.1016/j.neuropharm.2021.108565</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33891950</guid>
      <pubDate>Fri, 23 Apr 2021 06:00:00 -0400</pubDate>
      <dc:creator>Saobo Lei</dc:creator>
      <dc:creator>Binqi Hu</dc:creator>
      <dc:creator>Neda Rezagholizadeh</dc:creator>
      <dc:date>2021-04-23</dc:date>
      <dc:source>Neuropharmacology</dc:source>
      <dc:title>Activation of V&lt;sub&gt;1a&lt;/sub&gt; vasopressin receptors excite subicular pyramidal neurons by activating TRPV1 and depressing GIRK channels</dc:title>
      <dc:identifier>pmid:33891950</dc:identifier>
      <dc:identifier>pmc:PMC8169586</dc:identifier>
      <dc:identifier>doi:10.1016/j.neuropharm.2021.108565</dc:identifier>
    </item>
    <item>
      <title>Involvement of TRPC5 channels, inwardly rectifying K&lt;sup&gt;+&lt;/sup&gt; channels, PLCβ and PIP&lt;sub&gt;2&lt;/sub&gt; in vasopressin-mediated excitation of medial central amygdala neurons</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33871877/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Activation of V(1a) vasopressin receptors facilitates neuronal excitability in the medial nucleus of central amygdala (CeM) V(1a) receptor activation excites about 80% CeM neurons by opening a cationic conductance and about 20% CeM neurons by suppressing an inwardly rectifying K^(+) (Kir) channel The cationic conductance activated by V(1a) receptors is identified as TRPC5 channels PLCβ-mediated depletion of PIP(2) is involved in V(1a) receptor-elicited excitation of CeM neurons Intracellular...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Physiol. 2021 Jun;599(12):3101-3119. doi: 10.1113/JP281260. Epub 2021 Apr 27.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Activation of V<sub>1a</sub> vasopressin receptors facilitates neuronal excitability in the medial nucleus of central amygdala (CeM) V<sub>1a</sub> receptor activation excites about 80% CeM neurons by opening a cationic conductance and about 20% CeM neurons by suppressing an inwardly rectifying K<sup>+</sup> (Kir) channel The cationic conductance activated by V<sub>1a</sub> receptors is identified as TRPC5 channels PLCβ-mediated depletion of PIP<sub>2</sub> is involved in V<sub>1a</sub> receptor-elicited excitation of CeM neurons Intracellular Ca<sup>2+</sup> release and PKC are unnecessary for V<sub>1a</sub> receptor-mediated excitation of CeM neurons ABSTRACT: Arginine vasopressin (AVP) serves as a hormone in the periphery to modulate water homeostasis and a neuromodulator in the brain to regulate a diverse range of functions including anxiety, social behaviour, cognitive activities and nociception. The amygdala is an essential brain region involved in modulating defensive and appetitive behaviours, pain and alcohol use disorders. Whereas activation of V<sub>1a</sub> receptors in the medial nucleus of the central amygdala (CeM) increases neuronal excitability, the involved ionic and signalling mechanisms have not been determined. We found that activation of V<sub>1a</sub> receptors in the CeM facilitated neuronal excitability predominantly by opening TRPC5 channels, although AVP excited about one fifth of the CeM neurons via suppressing an inwardly rectifying K<sup>+</sup> (Kir) channel. G proteins and phospholipase Cβ (PLCβ) were required for AVP-elicited excitation of CeM neurons, whereas intracellular Ca<sup>2+</sup> release and the activity of protein kinase C were unnecessary. Prevention of the depletion of phosphatidylinositol 4,5-bisphosphate (PIP<sub>2</sub> ) blocked AVP-induced excitation of CeM neurons, suggesting that PLCβ-mediated depletion of PIP<sub>2</sub> is involved in AVP-mediated excitation of CeM neurons. Our results may provide a cellular and molecular mechanism to explain the anxiogenic effects of AVP in the amygdala.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33871877/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33871877</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8207704/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8207704</a> | DOI:<a href=https://doi.org/10.1113/JP281260>10.1113/JP281260</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33871877</guid>
      <pubDate>Mon, 19 Apr 2021 06:00:00 -0400</pubDate>
      <dc:creator>Cody A Boyle</dc:creator>
      <dc:creator>Binqi Hu</dc:creator>
      <dc:creator>Kati L Quaintance</dc:creator>
      <dc:creator>Saobo Lei</dc:creator>
      <dc:date>2021-04-19</dc:date>
      <dc:source>The Journal of physiology</dc:source>
      <dc:title>Involvement of TRPC5 channels, inwardly rectifying K&lt;sup&gt;+&lt;/sup&gt; channels, PLCβ and PIP&lt;sub&gt;2&lt;/sub&gt; in vasopressin-mediated excitation of medial central amygdala neurons</dc:title>
      <dc:identifier>pmid:33871877</dc:identifier>
      <dc:identifier>pmc:PMC8207704</dc:identifier>
      <dc:identifier>doi:10.1113/JP281260</dc:identifier>
    </item>
    <item>
      <title>Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington's Disease Mouse Striatum</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33815086/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Dysfunction at synapses is thought to be an early change contributing to cognitive, psychiatric and motor disturbances in Huntington's disease (HD). In neurons, mutant Huntingtin collects in aggregates and distributes to the same sites as wild-type Huntingtin including on membranes and in synapses. In this study, we investigated the biochemical integrity of synapses in HD mouse striatum. We performed subcellular fractionation of striatal tissue from 2 and 6-month old knock-in Q175/Q7 HD and...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Front Synaptic Neurosci. 2021 Mar 18;13:618391. doi: 10.3389/fnsyn.2021.618391. eCollection 2021.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dysfunction at synapses is thought to be an early change contributing to cognitive, psychiatric and motor disturbances in Huntington's disease (HD). In neurons, mutant Huntingtin collects in aggregates and distributes to the same sites as wild-type Huntingtin including on membranes and in synapses. In this study, we investigated the biochemical integrity of synapses in HD mouse striatum. We performed subcellular fractionation of striatal tissue from 2 and 6-month old knock-in Q175/Q7 HD and Q7/Q7 mice. Compared to striata of Q7/Q7 mice, proteins including GLUT3, Na<sup>+</sup>/K<sup>+</sup> ATPase, NMDAR 2b, PSD95, and VGLUT1 had altered distribution in Q175/Q7 HD striata of 6-month old mice but not 2-month old mice. These proteins are found on plasma membranes and pre- and postsynaptic membranes supporting hypotheses that functional changes at synapses contribute to cognitive and behavioral symptoms of HD. Lipidomic analysis of mouse fractions indicated that compared to those of wild-type, fractions 1 and 2 of 6 months Q175/Q7 HD had altered levels of two species of PIP2, a phospholipid involved in synaptic signaling, increased levels of cholesterol ester and decreased cardiolipin species. At 2 months, increased levels of species of acylcarnitine, phosphatidic acid and sphingomyelin were measured. EM analysis showed that the contents of fractions 1 and 2 of Q7/Q7 and Q175/Q7 HD striata had a mix of isolated synaptic vesicles, vesicle filled axon terminals singly or in clusters, and ER and endosome-like membranes. However, those of Q175/Q7 striata contained significantly fewer and larger clumps of particles compared to those of Q7/Q7. Human HD postmortem putamen showed differences from control putamen in subcellular distribution of two proteins (Calnexin and GLUT3). Our biochemical, lipidomic and EM analysis show that the presence of the HD mutation conferred age dependent disruption of localization of synaptic proteins and lipids important for synaptic function. Our data demonstrate concrete biochemical changes suggesting altered integrity of synaptic compartments in HD mice that may mirror changes in HD patients and presage cognitive and psychiatric changes that occur in premanifest HD.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33815086/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33815086</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8013775/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8013775</a> | DOI:<a href=https://doi.org/10.3389/fnsyn.2021.618391>10.3389/fnsyn.2021.618391</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33815086</guid>
      <pubDate>Mon, 05 Apr 2021 06:00:00 -0400</pubDate>
      <dc:creator>Maria Iuliano</dc:creator>
      <dc:creator>Connor Seeley</dc:creator>
      <dc:creator>Ellen Sapp</dc:creator>
      <dc:creator>Erin L Jones</dc:creator>
      <dc:creator>Callie Martin</dc:creator>
      <dc:creator>Xueyi Li</dc:creator>
      <dc:creator>Marian DiFiglia</dc:creator>
      <dc:creator>Kimberly B Kegel-Gleason</dc:creator>
      <dc:date>2021-04-05</dc:date>
      <dc:source>Frontiers in synaptic neuroscience</dc:source>
      <dc:title>Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington's Disease Mouse Striatum</dc:title>
      <dc:identifier>pmid:33815086</dc:identifier>
      <dc:identifier>pmc:PMC8013775</dc:identifier>
      <dc:identifier>doi:10.3389/fnsyn.2021.618391</dc:identifier>
    </item>
    <item>
      <title>Systemic metabolite profiling reveals sexual dimorphism of AIBP control of metabolism in mice</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33793635/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Emerging studies indicate that APOA-I binding protein (AIBP) is a secreted protein and functions extracellularly to promote cellular cholesterol efflux, thereby disrupting lipid rafts on the plasma membrane. AIBP is also present in the mitochondria and acts as an epimerase, facilitating the repair of dysfunctional hydrated NAD(P)H, known as NAD(P)H(X). Importantly, AIBP deficiency contributes to lethal neurometabolic disorder, reminiscent of the Leigh syndrome in humans. Whereas cyclic NADPHX...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">PLoS One. 2021 Apr 1;16(4):e0248964. doi: 10.1371/journal.pone.0248964. eCollection 2021.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Emerging studies indicate that APOA-I binding protein (AIBP) is a secreted protein and functions extracellularly to promote cellular cholesterol efflux, thereby disrupting lipid rafts on the plasma membrane. AIBP is also present in the mitochondria and acts as an epimerase, facilitating the repair of dysfunctional hydrated NAD(P)H, known as NAD(P)H(X). Importantly, AIBP deficiency contributes to lethal neurometabolic disorder, reminiscent of the Leigh syndrome in humans. Whereas cyclic NADPHX production is proposed to be the underlying cause, we hypothesize that an unbiased metabolic profiling may: 1) reveal new clues for the lethality, e.g., changes of mitochondrial metabolites., and 2) identify metabolites associated with new AIBP functions. To this end, we performed unbiased and profound metabolic studies of plasma obtained from adult AIBP knockout mice and control littermates of both genders. Our systemic metabolite profiling, encompassing 9 super pathways, identified a total of 640 compounds. Our studies demonstrate a surprising sexual dimorphism of metabolites affected by AIBP deletion, with more statistically significant changes in the AIBP knockout female vs male when compared with the corresponding controls. AIBP knockout trends to reduce cholesterol but increase the bile acid precursor 7-HOCA in female but not male. Complex lipids, phospholipids, sphingomyelin and plasmalogens were reduced, while monoacylglycerol, fatty acids and the lipid soluble vitamins E and carotene diol were elevated in AIBP knockout female but not male. NAD metabolites were not significantly different in AIBP knockout vs control mice but differed for male vs female mice. Metabolites associated with glycolysis and the Krebs cycle were unchanged by AIBP knockout. Importantly, polyamine spermidine, critical for many cellular functions including cerebral cortex synapses, was reduced in male but not female AIBP knockout. This is the first report of a systemic metabolite profile of plasma samples from AIBP knockout mice, and provides a metabolic basis for future studies of AIBP regulation of cellular metabolism and the pathophysiological presentation of AIBP deficiency in patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33793635/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33793635</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8016339/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8016339</a> | DOI:<a href=https://doi.org/10.1371/journal.pone.0248964>10.1371/journal.pone.0248964</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33793635</guid>
      <pubDate>Thu, 01 Apr 2021 06:00:00 -0400</pubDate>
      <dc:creator>Jun-Dae Kim</dc:creator>
      <dc:creator>Lingping Zhu</dc:creator>
      <dc:creator>Quan Sun</dc:creator>
      <dc:creator>Longhou Fang</dc:creator>
      <dc:date>2021-04-01</dc:date>
      <dc:source>PloS one</dc:source>
      <dc:title>Systemic metabolite profiling reveals sexual dimorphism of AIBP control of metabolism in mice</dc:title>
      <dc:identifier>pmid:33793635</dc:identifier>
      <dc:identifier>pmc:PMC8016339</dc:identifier>
      <dc:identifier>doi:10.1371/journal.pone.0248964</dc:identifier>
    </item>
    <item>
      <title>TMEM16F mediates bystander TCR-CD3 membrane dissociation at the immunological synapse and potentiates T cell activation</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33758060/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Electrostatic interactions regulate many aspects of T cell receptor (TCR) activity, including enabling the dynamic binding of the TCR-associated CD3ε and CD3ζ chains to anionic lipids in the plasma membrane to prevent spontaneous phosphorylation. Substantial changes in the electrostatic potential of the plasma membrane occur at the immunological synapse, the interface between a T cell and an antigen-presenting cell. Here, we investigated how the electrostatic interactions that promote dynamic...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Sci Signal. 2021 Mar 23;14(675):eabb5146. doi: 10.1126/scisignal.abb5146.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Electrostatic interactions regulate many aspects of T cell receptor (TCR) activity, including enabling the dynamic binding of the TCR-associated CD3ε and CD3ζ chains to anionic lipids in the plasma membrane to prevent spontaneous phosphorylation. Substantial changes in the electrostatic potential of the plasma membrane occur at the immunological synapse, the interface between a T cell and an antigen-presenting cell. Here, we investigated how the electrostatic interactions that promote dynamic membrane binding of the TCR-CD3 cytoplasmic domains are modulated during signaling and affect T cell activation. We found that Ca<sup>2+</sup>-dependent activation of the phosphatidylserine scramblase TMEM16F, which was previously implicated in T cell activation, reduced the electrostatic potential of the plasma membrane during immunological synapse formation by locally redistributing phosphatidylserine. This, in turn, increased the dissociation of bystander TCR-CD3 cytoplasmic domains from the plasma membrane and enhanced TCR-dependent signaling and consequently T cell activation. This study establishes the molecular basis for the role of TMEM16F in bystander TCR-induced signal amplification and identifies enhancement of TMEM16F function as a potential therapeutic strategy for promoting T cell activation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33758060/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33758060</a> | DOI:<a href=https://doi.org/10.1126/scisignal.abb5146>10.1126/scisignal.abb5146</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33758060</guid>
      <pubDate>Wed, 24 Mar 2021 06:00:00 -0400</pubDate>
      <dc:creator>Audrey Connolly</dc:creator>
      <dc:creator>Rébecca Panes</dc:creator>
      <dc:creator>Margaux Tual</dc:creator>
      <dc:creator>Raphaël Lafortune</dc:creator>
      <dc:creator>Angélique Bellemare-Pelletier</dc:creator>
      <dc:creator>Etienne Gagnon</dc:creator>
      <dc:date>2021-03-24</dc:date>
      <dc:source>Science signaling</dc:source>
      <dc:title>TMEM16F mediates bystander TCR-CD3 membrane dissociation at the immunological synapse and potentiates T cell activation</dc:title>
      <dc:identifier>pmid:33758060</dc:identifier>
      <dc:identifier>doi:10.1126/scisignal.abb5146</dc:identifier>
    </item>
    <item>
      <title>Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33730593/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synaptic vesicle (SV) docking is a dynamic multi-stage process that is required for efficient neurotransmitter release in response to nerve impulses. Although the steady-state SV docking likely involves the cooperation of Synaptotagmin-1 (Syt1) and soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), where and how the docking process initiates remains unknown. Phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) can interact with Syt1 and SNAREs to contribute to vesicle...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Cell Rep. 2021 Mar 16;34(11):108842. doi: 10.1016/j.celrep.2021.108842.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synaptic vesicle (SV) docking is a dynamic multi-stage process that is required for efficient neurotransmitter release in response to nerve impulses. Although the steady-state SV docking likely involves the cooperation of Synaptotagmin-1 (Syt1) and soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), where and how the docking process initiates remains unknown. Phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) can interact with Syt1 and SNAREs to contribute to vesicle exocytosis. In the present study, using the CRISPRi-mediated multiplex gene knockdown and 3D electron tomography approaches, we show that in mouse hippocampal synapses, SV docking initiates at ∼12 nm to the active zone (AZ) by Syt1. Furthermore, we demonstrate that PI(4,5)P2 is the membrane partner of Syt1 to initiate SV docking, and disrupting their interaction could abolish the docking initiation. In contrast, the SNARE complex contributes only to the tight SV docking within 0-2 nm. Therefore, Syt1 interacts with PI(4,5)P2 to loosely dock SVs within 2-12 nm to the AZ in hippocampal neurons.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33730593/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33730593</a> | DOI:<a href=https://doi.org/10.1016/j.celrep.2021.108842>10.1016/j.celrep.2021.108842</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33730593</guid>
      <pubDate>Wed, 17 Mar 2021 06:00:00 -0400</pubDate>
      <dc:creator>Yun Chen</dc:creator>
      <dc:creator>Ying-Han Wang</dc:creator>
      <dc:creator>Yi Zheng</dc:creator>
      <dc:creator>Meijing Li</dc:creator>
      <dc:creator>Bing Wang</dc:creator>
      <dc:creator>Qiu-Wen Wang</dc:creator>
      <dc:creator>Chong-Lei Fu</dc:creator>
      <dc:creator>Yao-Nan Liu</dc:creator>
      <dc:creator>Xueming Li</dc:creator>
      <dc:creator>Jun Yao</dc:creator>
      <dc:date>2021-03-17</dc:date>
      <dc:source>Cell reports</dc:source>
      <dc:title>Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons</dc:title>
      <dc:identifier>pmid:33730593</dc:identifier>
      <dc:identifier>doi:10.1016/j.celrep.2021.108842</dc:identifier>
    </item>
    <item>
      <title>Overview of how N32 and N34 elovanoids sustain sight by protecting retinal pigment epithelial cells and photoreceptors</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33662383/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The essential fatty acid DHA (22:6, omega-3 or n-3) is enriched in and required for the membrane biogenesis and function of photoreceptor cells (PRCs), synapses, mitochondria, etc. of the CNS. PRC DHA becomes an acyl chain at the sn-2 of phosphatidylcholine, amounting to more than 50% of the PRC outer segment phospholipids, where phototransduction takes place. Very long chain PUFAs (n-3, ≥ 28 carbons) are at the sn-1 of this phosphatidylcholine molecular species and interact with rhodopsin. PRC...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Lipid Res. 2021;62:100058. doi: 10.1194/jlr.TR120001137. Epub 2021 Mar 2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The essential fatty acid DHA (22:6, omega-3 or n-3) is enriched in and required for the membrane biogenesis and function of photoreceptor cells (PRCs), synapses, mitochondria, etc. of the CNS. PRC DHA becomes an acyl chain at the sn-2 of phosphatidylcholine, amounting to more than 50% of the PRC outer segment phospholipids, where phototransduction takes place. Very long chain PUFAs (n-3, ≥ 28 carbons) are at the sn-1 of this phosphatidylcholine molecular species and interact with rhodopsin. PRC shed their tips (DHA-rich membrane disks) daily, which in turn are phagocytized by the retinal pigment epithelium (RPE), where DHA is recycled back to PRC inner segments to be used for the biogenesis of new photoreceptor membranes. Here, we review the structures and stereochemistry of novel elovanoid (ELV)-N32 and ELV-N34 to be ELV-N32: (14Z,17Z,20R,21E,23E,25Z,27S,29Z)-20,27-dihydroxydo-triaconta-14,17,21,23,25,29-hexaenoic acid; ELV-N34: (16Z,19Z,22R,23E,25E,27Z,29S,31Z)-22,29-dihydroxytetra-triaconta-16,19,23,25,27,31-hexaenoic acid. ELVs are low-abundance, high-potency, protective mediators. Their bioactivity includes enhancing of antiapoptotic and prosurvival protein expression with concomitant downregulation of proapoptotic proteins when RPE is confronted with uncompensated oxidative stress. ELVs also target PRC/RPE senescence gene programming, the senescence secretory phenotype in the interphotoreceptor matrix, as well as inflammaging (chronic, sterile, low-grade inflammation). An important lesson on neuroprotection is highlighted by the ELV mediators that target the terminally differentiated PRC and RPE, sustaining a beautifully synchronized renewal process. The role of ELVs in PRC and RPE viability and function uncovers insights on disease mechanisms and the development of therapeutics for age-related macular degeneration, Alzheimer's disease, and other pathologies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33662383/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33662383</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8058566/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8058566</a> | DOI:<a href=https://doi.org/10.1194/jlr.TR120001137>10.1194/jlr.TR120001137</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33662383</guid>
      <pubDate>Thu, 04 Mar 2021 06:00:00 -0500</pubDate>
      <dc:creator>Nicolas G Bazan</dc:creator>
      <dc:date>2021-03-04</dc:date>
      <dc:source>Journal of lipid research</dc:source>
      <dc:title>Overview of how N32 and N34 elovanoids sustain sight by protecting retinal pigment epithelial cells and photoreceptors</dc:title>
      <dc:identifier>pmid:33662383</dc:identifier>
      <dc:identifier>pmc:PMC8058566</dc:identifier>
      <dc:identifier>doi:10.1194/jlr.TR120001137</dc:identifier>
    </item>
    <item>
      <title>Limb-clasping, cognitive deficit and increased vulnerability to kainic acid-induced seizures in neuronal glycosylphosphatidylinositol deficiency mouse models</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33607654/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Posttranslational modification of a protein with glycosylphosphatidylinositol (GPI) is a conserved mechanism exists in all eukaryotes. Thus far, &gt;150 human GPI-anchored proteins have been discovered and ~30 enzymes have been reported to be involved in the biosynthesis and maturation of mammalian GPI. Phosphatidylinositol glycan biosynthesis class A protein (PIGA) catalyzes the very first step of GPI anchor biosynthesis. Patients carrying a mutation of the PIGA gene usually suffer from inherited...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Hum Mol Genet. 2021 May 28;30(9):758-770. doi: 10.1093/hmg/ddab052.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Posttranslational modification of a protein with glycosylphosphatidylinositol (GPI) is a conserved mechanism exists in all eukaryotes. Thus far, &gt;150 human GPI-anchored proteins have been discovered and ~30 enzymes have been reported to be involved in the biosynthesis and maturation of mammalian GPI. Phosphatidylinositol glycan biosynthesis class A protein (PIGA) catalyzes the very first step of GPI anchor biosynthesis. Patients carrying a mutation of the PIGA gene usually suffer from inherited glycosylphosphatidylinositol deficiency (IGD) with intractable epilepsy and intellectual developmental disorder. We generated three mouse models with PIGA deficits specifically in telencephalon excitatory neurons (Ex-M-cko), inhibitory neurons (In-M-cko) or thalamic neurons (Th-H-cko), respectively. Both Ex-M-cko and In-M-cko mice showed impaired long-term fear memory and were more susceptible to kainic acid-induced seizures. In addition, In-M-cko demonstrated a severe limb-clasping phenotype. Hippocampal synapse changes were observed in Ex-M-cko mice. Our Piga conditional knockout mouse models provide powerful tools to understand the cell-type specific mechanisms underlying inherited GPI deficiency and to test different therapeutic modalities.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33607654/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33607654</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8161520/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8161520</a> | DOI:<a href=https://doi.org/10.1093/hmg/ddab052>10.1093/hmg/ddab052</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33607654</guid>
      <pubDate>Fri, 19 Feb 2021 06:00:00 -0500</pubDate>
      <dc:creator>Lenin C Kandasamy</dc:creator>
      <dc:creator>Mina Tsukamoto</dc:creator>
      <dc:creator>Vitaliy Banov</dc:creator>
      <dc:creator>Sambuu Tsetsegee</dc:creator>
      <dc:creator>Yutaro Nagasawa</dc:creator>
      <dc:creator>Mitsuhiro Kato</dc:creator>
      <dc:creator>Naomichi Matsumoto</dc:creator>
      <dc:creator>Junji Takeda</dc:creator>
      <dc:creator>Shigeyoshi Itohara</dc:creator>
      <dc:creator>Sonoko Ogawa</dc:creator>
      <dc:creator>Larry J Young</dc:creator>
      <dc:creator>Qi Zhang</dc:creator>
      <dc:date>2021-02-19</dc:date>
      <dc:source>Human molecular genetics</dc:source>
      <dc:title>Limb-clasping, cognitive deficit and increased vulnerability to kainic acid-induced seizures in neuronal glycosylphosphatidylinositol deficiency mouse models</dc:title>
      <dc:identifier>pmid:33607654</dc:identifier>
      <dc:identifier>pmc:PMC8161520</dc:identifier>
      <dc:identifier>doi:10.1093/hmg/ddab052</dc:identifier>
    </item>
    <item>
      <title>Synaptotagmin-1-, Munc18-1-, and Munc13-1-dependent liposome fusion with a few neuronal SNAREs</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33468652/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Neurotransmitter release is governed by eight central proteins among other factors: the neuronal SNAREs syntaxin-1, synaptobrevin, and SNAP-25, which form a tight SNARE complex that brings the synaptic vesicle and plasma membranes together; NSF and SNAPs, which disassemble SNARE complexes; Munc18-1 and Munc13-1, which organize SNARE complex assembly; and the Ca^(2+) sensor synaptotagmin-1. Reconstitution experiments revealed that Munc18-1, Munc13-1, NSF, and α-SNAP can mediate Ca^(2+)-dependent...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Proc Natl Acad Sci U S A. 2021 Jan 26;118(4):e2019314118. doi: 10.1073/pnas.2019314118.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neurotransmitter release is governed by eight central proteins among other factors: the neuronal SNAREs syntaxin-1, synaptobrevin, and SNAP-25, which form a tight SNARE complex that brings the synaptic vesicle and plasma membranes together; NSF and SNAPs, which disassemble SNARE complexes; Munc18-1 and Munc13-1, which organize SNARE complex assembly; and the Ca<sup>2+</sup> sensor synaptotagmin-1. Reconstitution experiments revealed that Munc18-1, Munc13-1, NSF, and α-SNAP can mediate Ca<sup>2+</sup>-dependent liposome fusion between synaptobrevin liposomes and syntaxin-1-SNAP-25 liposomes, but high fusion efficiency due to uncontrolled SNARE complex assembly did not allow investigation of the role of synaptotagmin-1 on fusion. Here, we show that decreasing the synaptobrevin-to-lipid ratio in the corresponding liposomes to very low levels leads to inefficient fusion and that synaptotagmin-1 strongly stimulates fusion under these conditions. Such stimulation depends on Ca<sup>2+</sup> binding to the two C<sub>2</sub> domains of synaptotagmin-1. We also show that anchoring SNAP-25 on the syntaxin-1 liposomes dramatically enhances fusion. Moreover, we uncover a synergy between synaptotagmin-1 and membrane anchoring of SNAP-25, which allows efficient Ca<sup>2+</sup>-dependent fusion between liposomes bearing very low synaptobrevin densities and liposomes containing very low syntaxin-1 densities. Thus, liposome fusion in our assays is achieved with a few SNARE complexes in a manner that requires Munc18-1 and Munc13-1 and that depends on Ca<sup>2+</sup> binding to synaptotagmin-1, all of which are fundamental features of neurotransmitter release in neurons.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33468652/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33468652</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7848701/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7848701</a> | DOI:<a href=https://doi.org/10.1073/pnas.2019314118>10.1073/pnas.2019314118</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33468652</guid>
      <pubDate>Wed, 20 Jan 2021 06:00:00 -0500</pubDate>
      <dc:creator>Karolina P Stepien</dc:creator>
      <dc:creator>Josep Rizo</dc:creator>
      <dc:date>2021-01-20</dc:date>
      <dc:source>Proceedings of the National Academy of Sciences of the United States of America</dc:source>
      <dc:title>Synaptotagmin-1-, Munc18-1-, and Munc13-1-dependent liposome fusion with a few neuronal SNAREs</dc:title>
      <dc:identifier>pmid:33468652</dc:identifier>
      <dc:identifier>pmc:PMC7848701</dc:identifier>
      <dc:identifier>doi:10.1073/pnas.2019314118</dc:identifier>
    </item>
    <item>
      <title>Membrane packing defects in synaptic vesicles recruit complexin and synuclein</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33437978/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Complexin-1 (Cpx) and α-synuclein (α-Syn) are involved in neurotransmitter release through an interaction with synaptic vesicles (SVs). Recent studies demonstrated that Cpx and α-Syn preferentially associate with highly curved membranes, like SVs, to correctly position them for fusion. Here, based on recent experimental results, to further propose a possible explanation for this mechanism, we performed in silico simulations probing interactions between Cpx or α-Syn and membranes of varying...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Phys Chem Chem Phys. 2021 Jan 28;23(3):2117-2125. doi: 10.1039/d0cp03546g.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Complexin-1 (Cpx) and α-synuclein (α-Syn) are involved in neurotransmitter release through an interaction with synaptic vesicles (SVs). Recent studies demonstrated that Cpx and α-Syn preferentially associate with highly curved membranes, like SVs, to correctly position them for fusion. Here, based on recent experimental results, to further propose a possible explanation for this mechanism, we performed in silico simulations probing interactions between Cpx or α-Syn and membranes of varying curvature. We found that the preferential association is attributed to smaller, curved membranes containing more packing defects that expose hydrophobic acyl tails, which may favorably interact with hydrophobic residues of Cpx and α-Syn. The number of membrane defects is proportional to the curvature and the size can be regulated by cholesterol.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33437978/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33437978</a> | DOI:<a href=https://doi.org/10.1039/d0cp03546g>10.1039/d0cp03546g</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33437978</guid>
      <pubDate>Wed, 13 Jan 2021 06:00:00 -0500</pubDate>
      <dc:creator>Jie Liu</dc:creator>
      <dc:creator>Bing Bu</dc:creator>
      <dc:creator>Michael Crowe</dc:creator>
      <dc:creator>Dechang Li</dc:creator>
      <dc:creator>Jiajie Diao</dc:creator>
      <dc:creator>Baohua Ji</dc:creator>
      <dc:date>2021-01-13</dc:date>
      <dc:source>Physical chemistry chemical physics : PCCP</dc:source>
      <dc:title>Membrane packing defects in synaptic vesicles recruit complexin and synuclein</dc:title>
      <dc:identifier>pmid:33437978</dc:identifier>
      <dc:identifier>doi:10.1039/d0cp03546g</dc:identifier>
    </item>
    <item>
      <title>Multiple signaling pathways are essential for synapse formation induced by synaptic adhesion molecules</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33431662/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Little is known about the cellular signals that organize synapse formation. To explore what signaling pathways may be involved, we employed heterologous synapse formation assays in which a synaptic adhesion molecule expressed in a nonneuronal cell induces pre- or postsynaptic specializations in cocultured neurons. We found that interfering pharmacologically with microtubules or actin filaments impaired heterologous synapse formation, whereas blocking protein synthesis had no effect....</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Proc Natl Acad Sci U S A. 2021 Jan 19;118(3):e2000173118. doi: 10.1073/pnas.2000173118.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Little is known about the cellular signals that organize synapse formation. To explore what signaling pathways may be involved, we employed heterologous synapse formation assays in which a synaptic adhesion molecule expressed in a nonneuronal cell induces pre- or postsynaptic specializations in cocultured neurons. We found that interfering pharmacologically with microtubules or actin filaments impaired heterologous synapse formation, whereas blocking protein synthesis had no effect. Unexpectedly, pharmacological inhibition of c-jun N-terminal kinases (JNKs), protein kinase-A (PKA), or AKT kinases also suppressed heterologous synapse formation, while inhibition of other tested signaling pathways-such as MAP kinases or protein kinase C-did not alter heterologous synapse formation. JNK and PKA inhibitors suppressed formation of both pre- and postsynaptic specializations, whereas AKT inhibitors impaired formation of post- but not presynaptic specializations. To independently test whether heterologous synapse formation depends on AKT signaling, we targeted PTEN, an enzyme that hydrolyzes phosphatidylinositol 3-phosphate and thereby prevents AKT kinase activation, to postsynaptic sites by fusing PTEN to Homer1. Targeting PTEN to postsynaptic specializations impaired heterologous postsynaptic synapse formation induced by presynaptic adhesion molecules, such as neurexins and additionally decreased excitatory synapse function in cultured neurons. Taken together, our results suggest that heterologous synapse formation is driven via a multifaceted and multistage kinase network, with diverse signals organizing pre- and postsynaptic specializations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33431662/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33431662</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7826368/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7826368</a> | DOI:<a href=https://doi.org/10.1073/pnas.2000173118>10.1073/pnas.2000173118</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33431662</guid>
      <pubDate>Tue, 12 Jan 2021 06:00:00 -0500</pubDate>
      <dc:creator>Xian Jiang</dc:creator>
      <dc:creator>Richard Sando</dc:creator>
      <dc:creator>Thomas C Südhof</dc:creator>
      <dc:date>2021-01-12</dc:date>
      <dc:source>Proceedings of the National Academy of Sciences of the United States of America</dc:source>
      <dc:title>Multiple signaling pathways are essential for synapse formation induced by synaptic adhesion molecules</dc:title>
      <dc:identifier>pmid:33431662</dc:identifier>
      <dc:identifier>pmc:PMC7826368</dc:identifier>
      <dc:identifier>doi:10.1073/pnas.2000173118</dc:identifier>
    </item>
    <item>
      <title>Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33421291/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>CONCLUSION: Anti-β2GPI and anti-prothrombin antibodies cause LA through different mechanisms of action: While anti-β2GPI antibodies interfere with FV activation by FXa through a direct interaction with FV, anti-prothrombin antibodies compete with FXa for phospholipid binding sites. These data provide leads for understanding the paradoxical association between thrombosis and a prolonged clotting time in the antiphospholipid syndrome.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Thromb Haemost. 2021 Apr;19(4):1018-1028. doi: 10.1111/jth.15241. Epub 2021 Feb 9.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: The presence of lupus anticoagulant (LA) is an independent risk factor for thrombosis. This laboratory phenomenon is detected as a phospholipid-dependent prolongation of the clotting time and is caused by autoantibodies against beta2-glycoprotein I (β2GPI) or prothrombin. How these autoantibodies cause LA is unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To elucidate how anti-β2GPI and anti-prothrombin antibodies cause the LA phenomenon.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The effects of monoclonal anti-β2GPI and anti-prothrombin antibodies on coagulation were analyzed in plasma and with purified coagulation factors.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Detection of LA caused by anti-β2GPI or anti-prothrombin antibodies required the presence of the procofactor factor V (FV) in plasma. LA effect disappeared when FV was replaced by activated FV (FVa), both in a model system and in patient plasma, although differences between anti-β2GPI and anti-prothrombin antibodies were observed. Further exploration of the effects of the antibodies on coagulation showed that the anti-β2GPI antibody attenuated FV activation by activated faxtor X (FXa), whereas the anti-prothrombin antibody did not. Binding studies showed that β2GPI--antibody complexes directly interacted with FV with high affinity. Anti-prothrombin complexes caused the LA phenomenon through competition for phospholipid binding sites with coagulation factors as reduced FXa binding to lipospheres was observed with flow cytometry in the presence of these antibodies.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Anti-β2GPI and anti-prothrombin antibodies cause LA through different mechanisms of action: While anti-β2GPI antibodies interfere with FV activation by FXa through a direct interaction with FV, anti-prothrombin antibodies compete with FXa for phospholipid binding sites. These data provide leads for understanding the paradoxical association between thrombosis and a prolonged clotting time in the antiphospholipid syndrome.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33421291/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33421291</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8048633/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8048633</a> | DOI:<a href=https://doi.org/10.1111/jth.15241>10.1111/jth.15241</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33421291</guid>
      <pubDate>Sat, 09 Jan 2021 06:00:00 -0500</pubDate>
      <dc:creator>Tessa Noordermeer</dc:creator>
      <dc:creator>Jessica E Molhoek</dc:creator>
      <dc:creator>Roger E G Schutgens</dc:creator>
      <dc:creator>Silvie A E Sebastian</dc:creator>
      <dc:creator>Sandra Drost-Verhoef</dc:creator>
      <dc:creator>Annet C W van Wesel</dc:creator>
      <dc:creator>Philip G de Groot</dc:creator>
      <dc:creator>Joost C M Meijers</dc:creator>
      <dc:creator>Rolf T Urbanus</dc:creator>
      <dc:date>2021-01-09</dc:date>
      <dc:source>Journal of thrombosis and haemostasis : JTH</dc:source>
      <dc:title>Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action</dc:title>
      <dc:identifier>pmid:33421291</dc:identifier>
      <dc:identifier>pmc:PMC8048633</dc:identifier>
      <dc:identifier>doi:10.1111/jth.15241</dc:identifier>
    </item>
    <item>
      <title>Short-term supplementation of DHA as phospholipids rather than triglycerides improve cognitive deficits induced by maternal omega-3 PUFA deficiency during the late postnatal stage</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33325958/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Cognitive deficiencies, which are caused by maternal omega-3 PUFA deficiency (O-3 Def), are likely to be more rapidly and easily reversed at younger ages with quicker DHA reversal. This study aims to compare the efficiency of short-term supplementation of DHA in the form of phospholipids (PL) and triglycerides (TG) and improve cognitive deficiency in the O-3 Def model during different periods of brain development (3-week and 7-week old). The animal's spatial task performance, brain PUFA...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Food Funct. 2021 Jan 21;12(2):564-572. doi: 10.1039/d0fo02552f. Epub 2020 Dec 16.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cognitive deficiencies, which are caused by maternal omega-3 PUFA deficiency (O-3 Def), are likely to be more rapidly and easily reversed at younger ages with quicker DHA reversal. This study aims to compare the efficiency of short-term supplementation of DHA in the form of phospholipids (PL) and triglycerides (TG) and improve cognitive deficiency in the O-3 Def model during different periods of brain development (3-week and 7-week old). The animal's spatial task performance, brain PUFA concentration, histopathology, and expression of synapse-associated proteins in the hippocampus were then analyzed. We demonstrate here that DHA-PL shows improved efficiency in improving cognitive deficiency compared to DHA-TG, particularly for adult O-3 Def offspring. The superiority of DHA-PL also correlates with the specific elevation of synapse-associated proteins, including BDNF, DCX, GAP-43, Syn, and PSD95, except to higher brain DHA accretion. This work highlights the DHA-PL as a better DHA supplement for inferior brain development caused by maternal O-3 Def, especially regarding those who missed the optimal time window of neurodevelopment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33325958/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33325958</a> | DOI:<a href=https://doi.org/10.1039/d0fo02552f>10.1039/d0fo02552f</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33325958</guid>
      <pubDate>Wed, 16 Dec 2020 06:00:00 -0500</pubDate>
      <dc:creator>Min Wen</dc:creator>
      <dc:creator>Yingcai Zhao</dc:creator>
      <dc:creator>Haohao Shi</dc:creator>
      <dc:creator>Chengcheng Wang</dc:creator>
      <dc:creator>Tiantian Zhang</dc:creator>
      <dc:creator>Yuming Wang</dc:creator>
      <dc:creator>Changhu Xue</dc:creator>
      <dc:date>2020-12-16</dc:date>
      <dc:source>Food &amp; function</dc:source>
      <dc:title>Short-term supplementation of DHA as phospholipids rather than triglycerides improve cognitive deficits induced by maternal omega-3 PUFA deficiency during the late postnatal stage</dc:title>
      <dc:identifier>pmid:33325958</dc:identifier>
      <dc:identifier>doi:10.1039/d0fo02552f</dc:identifier>
    </item>
    <item>
      <title>Souvenaid for Alzheimer's disease</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33320335/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>BACKGROUND: Souvenaid is a dietary supplement with a patented composition (Fortasyn Connect™)which is intended to be used by people with Alzheimer's disease (AD). It has been designed to support the formation and function of synapses in the brain, which are thought to be strongly correlated with cognitive function. If effective, it might improve symptoms of Alzheimer's disease and also prevent the progression from prodromal Alzheimer's disease to dementia. We sought in this review to examine the...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Cochrane Database Syst Rev. 2020 Dec 15;12(12):CD011679. doi: 10.1002/14651858.CD011679.pub2.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Souvenaid is a dietary supplement with a patented composition (Fortasyn Connect™)which is intended to be used by people with Alzheimer's disease (AD). It has been designed to support the formation and function of synapses in the brain, which are thought to be strongly correlated with cognitive function. If effective, it might improve symptoms of Alzheimer's disease and also prevent the progression from prodromal Alzheimer's disease to dementia. We sought in this review to examine the evidence for this proposition.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: To assess the effects of Souvenaid on incidence of dementia, cognition, functional performance, and safety in people with Alzheimer's disease.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SEARCH METHODS: We searched ALOIS, i.e. the specialised register of the Cochrane Dementia and Cognitive Improvement Group, MEDLINE (Ovid SP), Embase (Ovid SP), PsycINFO (Ovid SP), Web of Science (ISI Web of Science), Cinahl (EBSCOhost), Lilacs (BIREME), and clinical trials registries up to 24 June 2020. We also reviewed citations of reference lists of landmark papers, reviews, and included studies for additional studies and assessed their suitability for inclusion in the review.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">SELECTION CRITERIA: We included randomised, placebo-controlled trials which evaluated Souvenaid in people diagnosed with mild cognitive impairment (MCI) due to AD (also termed prodromal AD) or with dementia due to AD, and with a treatment duration of at least 16 weeks.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DATA COLLECTION AND ANALYSIS: Our primary outcome measures were incidence of dementia, global and specific cognitive function, functional performance, combined cognitive-functional outcomes and adverse events. We selected studies, extracted data, assessed the quality of trials and intended to conduct meta-analyses according to the Cochrane Handbook for Systematic Reviews of Interventions. We rated the quality of the evidence using the GRADE approach. We present all outcomes grouped by stage of AD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN RESULTS: We included three randomised, placebo-controlled trials investigating Souvenaid in 1097 community-dwelling participants with Alzheimer's disease. One study each included participants with prodromal AD, mild AD dementia and mild-to-moderate AD dementia. We rated the risks of bias of all trials as low. One study (in prodromal AD) was funded by European grants. The other two studies were funded by the manufacturer of Souvenaid. One trial investigated the incidence of dementia in people with prodromal AD at baseline, and found little to no difference between the Souvenaid group and the placebo group after 24 months (RR 1.09, 95% CI 0.82 to 1.43; 1 trial, 311 participants; moderate quality of evidence). In prodromal AD, and in mild and mild-to-moderate Alzheimer's disease dementia, Souvenaid probably results in little or no difference in global or specific cognitive functions (moderate quality of evidence). Everyday function, or the ability to perform activities of daily living, were measured in mild and mild-to-moderate AD dementia. Neither study found evidence of a difference between the groups after 24 weeks of treatment (moderate quality of evidence). Two studies investigated combined cognitive-functional outcomes with the Clinical Dementia Rating Sum of Boxes and observed conflicting results. Souvenaid probably results in slight improvement, which is below estimates of meaningful change, in participants with prodromal Alzheimer's disease after 24 months (moderate quality of evidence), but probably has little to no effect in mild-to-moderate Alzheimer's disease dementia after 24 weeks (moderate quality of evidence). Adverse effects observed were low in all trials, and the available data were insufficient to determine any connection with Souvenaid.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AUTHORS' CONCLUSIONS: Two years of treatment with Souvenaid probably does not reduce the risk of progression to dementia in people with prodromal AD. There is no convincing evidence that Souvenaid affects other outcomes important to people with AD in the prodromal stage or mild-to-moderate stages of dementia. Conflicting evidence on combined cognitive-functional outcomes in prodromal AD and mild AD dementia warrants further investigation. Adverse effects of Souvenaid seem to be uncommon, but the evidence synthesised in this review does not permit us to make a definitive statement on the long-term tolerability of Souvenaid. The effects of Souvenaid in more severe AD dementia or in people with AD at risk of nutritional deficiencies remain unclear.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33320335/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33320335</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC8094446/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC8094446</a> | DOI:<a href=https://doi.org/10.1002/14651858.CD011679.pub2>10.1002/14651858.CD011679.pub2</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33320335</guid>
      <pubDate>Tue, 15 Dec 2020 06:00:00 -0500</pubDate>
      <dc:creator>Marion Burckhardt</dc:creator>
      <dc:creator>Stefan Watzke</dc:creator>
      <dc:creator>Andreas Wienke</dc:creator>
      <dc:creator>Gero Langer</dc:creator>
      <dc:creator>Astrid Fink</dc:creator>
      <dc:date>2020-12-15</dc:date>
      <dc:source>The Cochrane database of systematic reviews</dc:source>
      <dc:title>Souvenaid for Alzheimer's disease</dc:title>
      <dc:identifier>pmid:33320335</dc:identifier>
      <dc:identifier>pmc:PMC8094446</dc:identifier>
      <dc:identifier>doi:10.1002/14651858.CD011679.pub2</dc:identifier>
    </item>
    <item>
      <title>Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33303387/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Phosphoinositide-specific phospholipases C (PI-PLCs) are a class of enzymes involved in the phosphatidylinositol metabolism, which is implicated in the activation of several signaling pathways and which controls several cellular processes. The scientific community has long accepted the existence of a nuclear phosphoinositide (PI) metabolism, independent from the cytoplasmic one, critical in nuclear function control. Indeed, nuclear PIs are involved in many activities, such as cell cycle...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Adv Biol Regul. 2021 Jan;79:100771. doi: 10.1016/j.jbior.2020.100771. Epub 2020 Nov 28.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Phosphoinositide-specific phospholipases C (PI-PLCs) are a class of enzymes involved in the phosphatidylinositol metabolism, which is implicated in the activation of several signaling pathways and which controls several cellular processes. The scientific community has long accepted the existence of a nuclear phosphoinositide (PI) metabolism, independent from the cytoplasmic one, critical in nuclear function control. Indeed, nuclear PIs are involved in many activities, such as cell cycle regulation, cell proliferation, cell differentiation, membrane transport, gene expression and cytoskeletal dynamics. There are several types of PIs and enzymes implicated in brain activities and among these enzymes, PI-PLCs contribute to a specific and complex network in the developing nervous system. Moreover, considering the abundant presence of PI-PLCβ1, PI-PLCγ1 and PI-PLCβ4 in the brain, a specific role for each PLC subtype has been suggested in the control of neuronal activity, which is important for synapse function, development and other mechanisms. The focus of this review is to describe the latest research about the involvement of PI-PLC signaling in the nervous system, both physiologically and in pathological conditions. Indeed, PI-PLC signaling imbalance seems to be also linked to several brain disorders including epilepsy, movement and behavior disorders, neurodegenerative diseases and, in addition, some PI-PLC subtypes could become potential novel signature genes for high-grade gliomas.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33303387/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33303387</a> | DOI:<a href=https://doi.org/10.1016/j.jbior.2020.100771>10.1016/j.jbior.2020.100771</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33303387</guid>
      <pubDate>Fri, 11 Dec 2020 06:00:00 -0500</pubDate>
      <dc:creator>Isabella Rusciano</dc:creator>
      <dc:creator>Maria Vittoria Marvi</dc:creator>
      <dc:creator>Eric Owusu Obeng</dc:creator>
      <dc:creator>Sara Mongiorgi</dc:creator>
      <dc:creator>Giulia Ramazzotti</dc:creator>
      <dc:creator>Matilde Y Follo</dc:creator>
      <dc:creator>Matteo Zoli</dc:creator>
      <dc:creator>Luca Morandi</dc:creator>
      <dc:creator>Sofia Asioli</dc:creator>
      <dc:creator>Viscardo Paolo Fabbri</dc:creator>
      <dc:creator>James A McCubrey</dc:creator>
      <dc:creator>Pann-Ghill Suh</dc:creator>
      <dc:creator>Lucia Manzoli</dc:creator>
      <dc:creator>Lucio Cocco</dc:creator>
      <dc:creator>Stefano Ratti</dc:creator>
      <dc:date>2020-12-11</dc:date>
      <dc:source>Advances in biological regulation</dc:source>
      <dc:title>Location-dependent role of phospholipase C signaling in the brain: Physiology and pathology</dc:title>
      <dc:identifier>pmid:33303387</dc:identifier>
      <dc:identifier>doi:10.1016/j.jbior.2020.100771</dc:identifier>
    </item>
    <item>
      <title>A positive feedback loop between Flower and PI(4,5)P&lt;sub&gt;2&lt;/sub&gt; at periactive zones controls bulk endocytosis in Drosophila</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33300871/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synaptic vesicle (SV) endocytosis is coupled to exocytosis to maintain SV pool size and thus neurotransmitter release. Intense stimulation induces activity-dependent bulk endocytosis (ADBE) to recapture large quantities of SV constituents in large endosomes from which SVs reform. How these consecutive processes are spatiotemporally coordinated remains unknown. Here, we show that Flower Ca^(2+) channel-dependent phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) compartmentalization governs...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Elife. 2020 Dec 10;9:e60125. doi: 10.7554/eLife.60125.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synaptic vesicle (SV) endocytosis is coupled to exocytosis to maintain SV pool size and thus neurotransmitter release. Intense stimulation induces activity-dependent bulk endocytosis (ADBE) to recapture large quantities of SV constituents in large endosomes from which SVs reform. How these consecutive processes are spatiotemporally coordinated remains unknown. Here, we show that Flower Ca<sup>2+</sup> channel-dependent phosphatidylinositol 4,5-bisphosphate (PI(4,5)P<sub>2</sub>) compartmentalization governs control of these processes in <i>Drosophila</i>. Strong stimuli trigger PI(4,5)P<sub>2</sub> microdomain formation at periactive zones. Upon exocytosis, Flower translocates from SVs to periactive zones, where it increases PI(4,5)P<sub>2</sub> levels via Ca<sup>2+</sup> influxes. Remarkably, PI(4,5)P<sub>2</sub> directly enhances Flower channel activity, thereby establishing a positive feedback loop for PI(4,5)P<sub>2</sub> microdomain compartmentalization. PI(4,5)P<sub>2</sub> microdomains drive ADBE and SV reformation from bulk endosomes. PI(4,5)P<sub>2</sub> further retrieves Flower to bulk endosomes, terminating endocytosis. We propose that the interplay between Flower and PI(4,5)P<sub>2</sub> is the crucial spatiotemporal cue that couples exocytosis to ADBE and subsequent SV reformation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33300871/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33300871</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7748424/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7748424</a> | DOI:<a href=https://doi.org/10.7554/eLife.60125>10.7554/eLife.60125</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33300871</guid>
      <pubDate>Thu, 10 Dec 2020 06:00:00 -0500</pubDate>
      <dc:creator>Tsai-Ning Li</dc:creator>
      <dc:creator>Yu-Jung Chen</dc:creator>
      <dc:creator>Ting-Yi Lu</dc:creator>
      <dc:creator>You-Tung Wang</dc:creator>
      <dc:creator>Hsin-Chieh Lin</dc:creator>
      <dc:creator>Chi-Kuang Yao</dc:creator>
      <dc:date>2020-12-10</dc:date>
      <dc:source>eLife</dc:source>
      <dc:title>A positive feedback loop between Flower and PI(4,5)P&lt;sub&gt;2&lt;/sub&gt; at periactive zones controls bulk endocytosis in Drosophila</dc:title>
      <dc:identifier>pmid:33300871</dc:identifier>
      <dc:identifier>pmc:PMC7748424</dc:identifier>
      <dc:identifier>doi:10.7554/eLife.60125</dc:identifier>
    </item>
    <item>
      <title>Neuroligin-2 dependent conformational activation of collybistin reconstituted in supported hybrid membranes</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33127642/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The assembly of the postsynaptic transmitter sensing machinery at inhibitory nerve cell synapses requires the intimate interplay between cell adhesion proteins, scaffold and adaptor proteins, and γ-aminobutyric acid (GABA) or glycine receptors. We developed an in vitro membrane system to reconstitute this process, to identify the essential protein components, and to define their mechanism of action, with a specific focus on the mechanism by which the cytosolic C terminus of the synaptic cell...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Biol Chem. 2020 Dec 25;295(52):18604-18613. doi: 10.1074/jbc.RA120.015347. Epub 2020 Oct 30.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The assembly of the postsynaptic transmitter sensing machinery at inhibitory nerve cell synapses requires the intimate interplay between cell adhesion proteins, scaffold and adaptor proteins, and γ-aminobutyric acid (GABA) or glycine receptors. We developed an <i>in vitro</i> membrane system to reconstitute this process, to identify the essential protein components, and to define their mechanism of action, with a specific focus on the mechanism by which the cytosolic <i>C terminus</i> of the synaptic cell adhesion protein Neuroligin-2 alters the conformation of the adaptor protein Collybistin-2 and thereby controls Collybistin-2-interactions with phosphoinositides (PtdInsPs) in the plasma membrane. Supported hybrid membranes doped with different PtdInsPs and 1,2-dioleoyl-<i>sn</i>-glycero-3-{[<i>N</i>-(5-amino-1-carboxypentyl)iminodiacetic acid]succinyl} nickel salt (DGS-NTA(Ni)) to allow for the specific adsorption of the His<sub>6</sub>-tagged intracellular domain of Neuroligin-2 (His-<i>cyt</i>NL2) were prepared on hydrophobically functionalized silicon dioxide substrates via vesicle spreading. Two different collybistin variants, the WT protein (CB2<sub>SH3</sub>) and a mutant that adopts an intrinsically 'open' and activated conformation (CB2<sub>SH3/W24A-E262A</sub>), were bound to supported membranes in the absence or presence of His-<i>cyt</i>NL2. The corresponding binding data, obtained by reflectometric interference spectroscopy, show that the interaction of the <i>C terminus</i> of Neuroligin-2 with Collybistin-2 induces a conformational change in Collybistin-2 that promotes its interaction with distinct membrane PtdInsPs.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33127642/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33127642</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7939476/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7939476</a> | DOI:<a href=https://doi.org/10.1074/jbc.RA120.015347>10.1074/jbc.RA120.015347</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33127642</guid>
      <pubDate>Sat, 31 Oct 2020 06:00:00 -0400</pubDate>
      <dc:creator>Jonas Schäfer</dc:creator>
      <dc:creator>Lucas Förster</dc:creator>
      <dc:creator>Ingo Mey</dc:creator>
      <dc:creator>Theofilos Papadopoulos</dc:creator>
      <dc:creator>Nils Brose</dc:creator>
      <dc:creator>Claudia Steinem</dc:creator>
      <dc:date>2020-10-31</dc:date>
      <dc:source>The Journal of biological chemistry</dc:source>
      <dc:title>Neuroligin-2 dependent conformational activation of collybistin reconstituted in supported hybrid membranes</dc:title>
      <dc:identifier>pmid:33127642</dc:identifier>
      <dc:identifier>pmc:PMC7939476</dc:identifier>
      <dc:identifier>doi:10.1074/jbc.RA120.015347</dc:identifier>
    </item>
    <item>
      <title>α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/33087443/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>α-Synuclein (α-Syn) is a protein implicated in the pathogenesis of Parkinson's disease (PD). It is an intrinsically disordered protein that binds acidic phospholipids. Growing evidence supports a role for α-Syn in membrane trafficking, including, mechanisms of endocytosis and exocytosis, although the exact role of α-Syn in these mechanisms is currently unclear. Here we investigate the associations of α-Syn with the acidic phosphoinositides (PIPs), phosphatidylinositol 4,5-bisphosphate...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Biol Chem. 2020 Dec 25;295(52):18076-18090. doi: 10.1074/jbc.RA120.015319. Epub 2020 Oct 21.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">α-Synuclein (α-Syn) is a protein implicated in the pathogenesis of Parkinson's disease (PD). It is an intrinsically disordered protein that binds acidic phospholipids. Growing evidence supports a role for α-Syn in membrane trafficking, including, mechanisms of endocytosis and exocytosis, although the exact role of α-Syn in these mechanisms is currently unclear. Here we investigate the associations of α-Syn with the acidic phosphoinositides (PIPs), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P<sub>2</sub>) and phosphatidylinositol 3,4-bisphosphate (PI(3,4)P<sub>2</sub>). Our results show that α-Syn colocalizes with PIP<sub>2</sub> and the phosphorylated active form of the clathrin adaptor protein 2 (AP2) at clathrin-coated pits. Using endocytosis of transferrin as an indicator for clathrin-mediated endocytosis (CME), we find that α-Syn involvement in endocytosis is specifically mediated through PI(4,5)P<sub>2</sub> levels on the plasma membrane. In accord with their effects on PI(4,5)P<sub>2</sub> levels, the PD associated A30P, E46K, and A53T mutations in α-Syn further enhance CME in neuronal and nonneuronal cells. However, lysine to glutamic acid substitutions at the KTKEGV repeat domain of α-Syn, which interfere with phospholipid binding, are ineffective in enhancing CME. We further show that the rate of synaptic vesicle (SV) endocytosis is differentially affected by the α-Syn mutations and associates with their effects on PI(4,5)P<sub>2</sub> levels, however, with the exception of the A30P mutation. This study provides evidence for a critical involvement of PIPs in α-Syn-mediated membrane trafficking.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/33087443/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">33087443</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7939461/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7939461</a> | DOI:<a href=https://doi.org/10.1074/jbc.RA120.015319>10.1074/jbc.RA120.015319</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:33087443</guid>
      <pubDate>Thu, 22 Oct 2020 06:00:00 -0400</pubDate>
      <dc:creator>Meir Schechter</dc:creator>
      <dc:creator>Merav Atias</dc:creator>
      <dc:creator>Suaad Abd Elhadi</dc:creator>
      <dc:creator>Dana Davidi</dc:creator>
      <dc:creator>Daniel Gitler</dc:creator>
      <dc:creator>Ronit Sharon</dc:creator>
      <dc:date>2020-10-22</dc:date>
      <dc:source>The Journal of biological chemistry</dc:source>
      <dc:title>α-Synuclein facilitates endocytosis by elevating the steady-state levels of phosphatidylinositol 4,5-bisphosphate</dc:title>
      <dc:identifier>pmid:33087443</dc:identifier>
      <dc:identifier>pmc:PMC7939461</dc:identifier>
      <dc:identifier>doi:10.1074/jbc.RA120.015319</dc:identifier>
    </item>
    <item>
      <title>PLRP2 selectively localizes synaptic membrane proteins via acyl-chain remodeling of phospholipids</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32963038/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The plasma membrane of neurons consists of distinct domains, each of which carries specialized functions and a characteristic set of membrane proteins. While this compartmentalized membrane organization is essential for neuronal functions, it remains controversial how neurons establish these domains on the laterally fluid membrane. Here, using immunostaining, lipid-MS analysis and gene ablation with the CRISPR/Cas9 system, we report that the pancreatic lipase-related protein 2 (PLRP2), a...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">J Lipid Res. 2020 Dec;61(12):1747-1763. doi: 10.1194/jlr.RA120001087. Epub 2020 Sep 22.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The plasma membrane of neurons consists of distinct domains, each of which carries specialized functions and a characteristic set of membrane proteins. While this compartmentalized membrane organization is essential for neuronal functions, it remains controversial how neurons establish these domains on the laterally fluid membrane. Here, using immunostaining, lipid-MS analysis and gene ablation with the CRISPR/Cas9 system, we report that the pancreatic lipase-related protein 2 (PLRP2), a phospholipase A1 (PLA1), is a key organizer of membrane protein localization at the neurite tips of PC12 cells. PLRP2 produced local distribution of 1-oleoyl-2-palmitoyl-PC at these sites through acyl-chain remodeling of membrane phospholipids. The resulting lipid domain assembled the syntaxin 4 (Stx4) protein within itself by selectively interacting with the transmembrane domain of Stx4. The localized Stx4, in turn, facilitated the fusion of transport vesicles that contained the dopamine transporter with the domain of the plasma membrane, which led to the localized distribution of the transporter to that domain. These results revealed the pivotal roles of PLA1, specifically PLRP2, in the formation of functional domains in the plasma membrane of neurons. In addition, our results suggest a mode of membrane organization in which the local acyl-chain remodeling of membrane phospholipids controls the selective localization of membrane proteins by regulating both lipid-protein interactions and the fusion of transport vesicles to the lipid domain.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32963038/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32963038</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7707162/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7707162</a> | DOI:<a href=https://doi.org/10.1194/jlr.RA120001087>10.1194/jlr.RA120001087</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32963038</guid>
      <pubDate>Wed, 23 Sep 2020 06:00:00 -0400</pubDate>
      <dc:creator>Hideaki Kuge</dc:creator>
      <dc:creator>Izumi Miyamoto</dc:creator>
      <dc:creator>Ken-Ichi Yagyu</dc:creator>
      <dc:creator>Koichi Honke</dc:creator>
      <dc:date>2020-09-23</dc:date>
      <dc:source>Journal of lipid research</dc:source>
      <dc:title>PLRP2 selectively localizes synaptic membrane proteins via acyl-chain remodeling of phospholipids</dc:title>
      <dc:identifier>pmid:32963038</dc:identifier>
      <dc:identifier>pmc:PMC7707162</dc:identifier>
      <dc:identifier>doi:10.1194/jlr.RA120001087</dc:identifier>
    </item>
    <item>
      <title>Protein-lipid architecture of a cholinergic postsynaptic membrane</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32939277/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The cholinergic postsynaptic membrane is an acetyl-choline receptor-rich membrane mediating fast chemical communication at the nerve-muscle synapse. Here, cryo-EM is used to examine the protein-lipid architecture of this membrane in tubular vesicles obtained from the (muscle-derived) electric organ of the Torpedo ray. As reported earlier, the helical arrangement of the protein component of the vesicles facilitates image averaging and enables us to determine how cholesterol and phospho-lipid...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">IUCrJ. 2020 Jul 28;7(Pt 5):852-859. doi: 10.1107/S2052252520009446. eCollection 2020 Sep 1.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The cholinergic postsynaptic membrane is an acetyl-choline receptor-rich membrane mediating fast chemical communication at the nerve-muscle synapse. Here, cryo-EM is used to examine the protein-lipid architecture of this membrane in tubular vesicles obtained from the (muscle-derived) electric organ of the <i>Torpedo</i> ray. As reported earlier, the helical arrangement of the protein component of the vesicles facilitates image averaging and enables us to determine how cholesterol and phospho-lipid molecules are distributed in the surrounding matrix, using headgroup size as a means to discriminate between the two kinds of lipid. It is shown that cholesterol segregates preferentially around the receptors in both leaflets of the lipid bilayer, interacting robustly with specific transmembrane sites and creating a network of bridging microdomains. Cholesterol interactions with the receptor are apparently essential for stabilizing and maintaining its physiological architecture, since the transmembrane structure contracts, involving displacements of the helices at the outer membrane surface by ∼2 Å (1-3 Å), when this lipid is extracted. The microdomains may promote cooperativity between neighbouring receptors, leading to an enhanced postsynaptic response.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32939277/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32939277</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7467168/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7467168</a> | DOI:<a href=https://doi.org/10.1107/S2052252520009446>10.1107/S2052252520009446</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32939277</guid>
      <pubDate>Thu, 17 Sep 2020 06:00:00 -0400</pubDate>
      <dc:creator>Nigel Unwin</dc:creator>
      <dc:date>2020-09-17</dc:date>
      <dc:source>IUCrJ</dc:source>
      <dc:title>Protein-lipid architecture of a cholinergic postsynaptic membrane</dc:title>
      <dc:identifier>pmid:32939277</dc:identifier>
      <dc:identifier>pmc:PMC7467168</dc:identifier>
      <dc:identifier>doi:10.1107/S2052252520009446</dc:identifier>
    </item>
    <item>
      <title>Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32808925/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The Ca^(2+) sensor synaptotagmin-1 and the SNARE complex cooperate to trigger neurotransmitter release. Structural studies elucidated three distinct synaptotagmin-1-SNARE complex binding modes involving 'polybasic', 'primary' and 'tripartite' interfaces of synaptotagmin-1. We investigated these interactions using NMR and fluorescence spectroscopy. Synaptotagmin-1 binds to the SNARE complex through the polybasic and primary interfaces in solution. Ca^(2+)-free synaptotagmin-1 binds to SNARE...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Elife. 2020 Aug 18;9:e57154. doi: 10.7554/eLife.57154.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The Ca<sup>2+</sup> sensor synaptotagmin-1 and the SNARE complex cooperate to trigger neurotransmitter release. Structural studies elucidated three distinct synaptotagmin-1-SNARE complex binding modes involving 'polybasic', 'primary' and 'tripartite' interfaces of synaptotagmin-1. We investigated these interactions using NMR and fluorescence spectroscopy. Synaptotagmin-1 binds to the SNARE complex through the polybasic and primary interfaces in solution. Ca<sup>2+</sup>-free synaptotagmin-1 binds to SNARE complexes anchored on PIP<sub>2</sub>-containing nanodiscs. R398Q/R399Q and E295A/Y338W mutations at the primary interface, which strongly impair neurotransmitter release, disrupt and enhance synaptotagmin-1-SNARE complex binding, respectively. Ca<sup>2+</sup> induces tight binding of synaptotagmin-1 to PIP<sub>2</sub>-containing nanodiscs, disrupting synaptotagmin-1-SNARE interactions. Specific effects of mutations in the polybasic region on Ca<sup>2+</sup>-dependent synaptotagmin-1-PIP<sub>2</sub>-membrane interactions correlate with their effects on release. Our data suggest that synaptotagmin-1 binds to the SNARE complex through the primary interface and that Ca<sup>2+</sup> releases this interaction, inducing PIP<sub>2</sub>/membrane binding and allowing cooperation between synaptotagmin-1 and the SNAREs in membrane fusion to trigger release.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32808925/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32808925</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7498268/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7498268</a> | DOI:<a href=https://doi.org/10.7554/eLife.57154>10.7554/eLife.57154</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32808925</guid>
      <pubDate>Wed, 19 Aug 2020 06:00:00 -0400</pubDate>
      <dc:creator>Rashmi Voleti</dc:creator>
      <dc:creator>Klaudia Jaczynska</dc:creator>
      <dc:creator>Josep Rizo</dc:creator>
      <dc:date>2020-08-19</dc:date>
      <dc:source>eLife</dc:source>
      <dc:title>Ca&lt;sup&gt;2+&lt;/sup&gt;-dependent release of synaptotagmin-1 from the SNARE complex on phosphatidylinositol 4,5-bisphosphate-containing membranes</dc:title>
      <dc:identifier>pmid:32808925</dc:identifier>
      <dc:identifier>pmc:PMC7498268</dc:identifier>
      <dc:identifier>doi:10.7554/eLife.57154</dc:identifier>
    </item>
    <item>
      <title>CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32768386/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>CD47 acts as a "don't eat me" signal that protects cells from phagocytosis by binding and activating its receptor SIPRA on macrophages. CD47 suppresses multiple different pro-engulfment "eat me" signals, including immunoglobulin G (IgG), complement, and calreticulin, on distinct target cells. This complexity has limited understanding of how the "don't eat me" signal is transduced biochemically. Here, we utilized a reconstituted system with a defined set of signals to interrogate the mechanism of...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Immunity. 2020 Aug 18;53(2):290-302.e6. doi: 10.1016/j.immuni.2020.07.008. Epub 2020 Aug 7.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CD47 acts as a "don't eat me" signal that protects cells from phagocytosis by binding and activating its receptor SIPRA on macrophages. CD47 suppresses multiple different pro-engulfment "eat me" signals, including immunoglobulin G (IgG), complement, and calreticulin, on distinct target cells. This complexity has limited understanding of how the "don't eat me" signal is transduced biochemically. Here, we utilized a reconstituted system with a defined set of signals to interrogate the mechanism of SIRPA activation and its downstream targets. CD47 ligation altered SIRPA localization, positioning SIRPA for activation at the phagocytic synapse. At the phagocytic synapse, SIRPA inhibited integrin activation to limit macrophage spreading across the surface of the engulfment target. Chemical reactivation of integrin bypassed CD47-mediated inhibition and rescued engulfment, similar to the effect of a CD47 function-blocking antibody. Thus, the CD47-SIRPA axis suppresses phagocytosis by inhibiting inside-out activation of integrin signaling in the macrophage, with implications to cancer immunotherapy applications.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32768386/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32768386</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7453839/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7453839</a> | DOI:<a href=https://doi.org/10.1016/j.immuni.2020.07.008>10.1016/j.immuni.2020.07.008</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32768386</guid>
      <pubDate>Mon, 10 Aug 2020 06:00:00 -0400</pubDate>
      <dc:creator>Meghan A Morrissey</dc:creator>
      <dc:creator>Nadja Kern</dc:creator>
      <dc:creator>Ronald D Vale</dc:creator>
      <dc:date>2020-08-10</dc:date>
      <dc:source>Immunity</dc:source>
      <dc:title>CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis</dc:title>
      <dc:identifier>pmid:32768386</dc:identifier>
      <dc:identifier>pmc:PMC7453839</dc:identifier>
      <dc:identifier>doi:10.1016/j.immuni.2020.07.008</dc:identifier>
    </item>
    <item>
      <title>Please eat (only part) of me: synaptic phosphatidylserine cues microglia to feast: Two new studies identify how a common apoptotic cell flag is used to sculpt neural circuits</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32705698/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Microglia, the brain's tissue-resident macrophages, contribute to the developmental elimination of extranumerary synapses and to pathologic synapse loss in mouse models of neurodegeneration. Two papers published in The EMBO Journal reveal that phosphatidylserine (PS) is a neuronal cue for microglial synapse elimination.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2020 Aug 17;39(16):e105924. doi: 10.15252/embj.2020105924. Epub 2020 Jul 23.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Microglia, the brain's tissue-resident macrophages, contribute to the developmental elimination of extranumerary synapses and to pathologic synapse loss in mouse models of neurodegeneration. Two papers published in The EMBO Journal reveal that phosphatidylserine (PS) is a neuronal cue for microglial synapse elimination.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32705698/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32705698</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7429477/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7429477</a> | DOI:<a href=https://doi.org/10.15252/embj.2020105924>10.15252/embj.2020105924</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32705698</guid>
      <pubDate>Sat, 25 Jul 2020 06:00:00 -0400</pubDate>
      <dc:creator>Graham Peet</dc:creator>
      <dc:creator>F Chris Bennett</dc:creator>
      <dc:creator>Mariko L Bennett</dc:creator>
      <dc:date>2020-07-25</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>Please eat (only part) of me: synaptic phosphatidylserine cues microglia to feast: Two new studies identify how a common apoptotic cell flag is used to sculpt neural circuits</dc:title>
      <dc:identifier>pmid:32705698</dc:identifier>
      <dc:identifier>pmc:PMC7429477</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2020105924</dc:identifier>
    </item>
    <item>
      <title>Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32657463/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Neuronal circuit assembly requires the fine balance between synapse formation and elimination. Microglia, through the elimination of supernumerary synapses, have an established role in this process. While the microglial receptor TREM2 and the soluble complement proteins C1q and C3 are recognized as key players, the neuronal molecular components that specify synapses to be eliminated are still undefined. Here, we show that exposed phosphatidylserine (PS) represents a neuronal "eat-me" signal...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2020 Aug 17;39(16):e105380. doi: 10.15252/embj.2020105380. Epub 2020 Jul 13.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neuronal circuit assembly requires the fine balance between synapse formation and elimination. Microglia, through the elimination of supernumerary synapses, have an established role in this process. While the microglial receptor TREM2 and the soluble complement proteins C1q and C3 are recognized as key players, the neuronal molecular components that specify synapses to be eliminated are still undefined. Here, we show that exposed phosphatidylserine (PS) represents a neuronal "eat-me" signal involved in microglial-mediated pruning. In hippocampal neuron and microglia co-cultures, synapse elimination can be partially prevented by blocking accessibility of exposed PS using Annexin V or through microglial loss of TREM2. In vivo, PS exposure at both hippocampal and retinogeniculate synapses and engulfment of PS-labeled material by microglia occurs during established developmental periods of microglial-mediated synapse elimination. Mice deficient in C1q, which fail to properly refine retinogeniculate connections, have elevated presynaptic PS exposure and reduced PS engulfment by microglia. These data provide mechanistic insight into microglial-mediated synapse pruning and identify a novel role of developmentally regulated neuronal PS exposure that is common among developing brain structures.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32657463/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32657463</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7429741/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7429741</a> | DOI:<a href=https://doi.org/10.15252/embj.2020105380>10.15252/embj.2020105380</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32657463</guid>
      <pubDate>Tue, 14 Jul 2020 06:00:00 -0400</pubDate>
      <dc:creator>Nicole Scott-Hewitt</dc:creator>
      <dc:creator>Fabio Perrucci</dc:creator>
      <dc:creator>Raffaella Morini</dc:creator>
      <dc:creator>Marco Erreni</dc:creator>
      <dc:creator>Matthew Mahoney</dc:creator>
      <dc:creator>Agata Witkowska</dc:creator>
      <dc:creator>Alanna Carey</dc:creator>
      <dc:creator>Elisa Faggiani</dc:creator>
      <dc:creator>Lisa Theresia Schuetz</dc:creator>
      <dc:creator>Sydney Mason</dc:creator>
      <dc:creator>Matteo Tamborini</dc:creator>
      <dc:creator>Matteo Bizzotto</dc:creator>
      <dc:creator>Lorena Passoni</dc:creator>
      <dc:creator>Fabia Filipello</dc:creator>
      <dc:creator>Reinhard Jahn</dc:creator>
      <dc:creator>Beth Stevens</dc:creator>
      <dc:creator>Michela Matteoli</dc:creator>
      <dc:date>2020-07-14</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia</dc:title>
      <dc:identifier>pmid:32657463</dc:identifier>
      <dc:identifier>pmc:PMC7429741</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2020105380</dc:identifier>
    </item>
    <item>
      <title>Raman Probes for &lt;em&gt;In Situ&lt;/em&gt; Molecular Analyses of Peripheral Nerve Myelination</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32603086/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>The myelinating activity of living Schwann cells in coculture with neuronal cells was examined in situ in a Raman microprobe spectroscope. The Raman label-free approach revealed vibrational fingerprints directly related to the activity of Schwann cells' metabolites and identified molecular species peculiar to myelinating cells. The identified chemical species included antioxidants, such as hypotaurine and glutathione, and compartmentalized water, in addition to sphingolipids, phospholipids, and...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">ACS Chem Neurosci. 2020 Aug 5;11(15):2327-2339. doi: 10.1021/acschemneuro.0c00284. Epub 2020 Jul 14.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The myelinating activity of living Schwann cells in coculture with neuronal cells was examined <i>in situ</i> in a Raman microprobe spectroscope. The Raman label-free approach revealed vibrational fingerprints directly related to the activity of Schwann cells' metabolites and identified molecular species peculiar to myelinating cells. The identified chemical species included antioxidants, such as hypotaurine and glutathione, and compartmentalized water, in addition to sphingolipids, phospholipids, and nucleoside triphosphates also present in neuronal and nonmyelinating Schwann cells. Raman maps at specific frequencies could be collected, which clearly visualized the myelinating action of Schwann cells and located the demyelinated ones. An important finding was the spectroscopic visualization of confined water in the myelin structure, which exhibited a quite pronounced Raman signal at ∼3470 cm<sup>-1</sup>. This peculiar signal, whose spatial location precisely corresponded to a low-frequency fingerprint of hypotaurine, was absent in unmyelinating cells and in bulk water. Raman enhancement was attributed to frustration in the hydrogen-bond network as induced by interactions with lipids in the myelin sheaths. According to a generally accepted morphological model of myelin, an explanation was offered of the peculiar Raman scattering of water confined in intraperiod lines, according to an ordered hydrogen bonding structure. The possibility of concurrently mapping antioxidant molecules and compartmentalized water structure with high spectral accuracy and microscopic spatial resolution enables probing myelinating activity and might play a key-role in future studies of neuronal pathologies. Compatible with life, Raman microprobe spectroscopy with the newly discovered probes could be suitable for developing advanced strategies in the reconstruction of injured nerves and nerve terminals at neuromuscular junctions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32603086/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32603086</a> | DOI:<a href=https://doi.org/10.1021/acschemneuro.0c00284>10.1021/acschemneuro.0c00284</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32603086</guid>
      <pubDate>Wed, 01 Jul 2020 06:00:00 -0400</pubDate>
      <dc:creator>Giuseppe Pezzotti</dc:creator>
      <dc:creator>Tetsuya Adachi</dc:creator>
      <dc:creator>Nao Miyamoto</dc:creator>
      <dc:creator>Toshiro Yamamoto</dc:creator>
      <dc:creator>Francesco Boschetto</dc:creator>
      <dc:creator>Elia Marin</dc:creator>
      <dc:creator>Wenliang Zhu</dc:creator>
      <dc:creator>Narisato Kanamura</dc:creator>
      <dc:creator>Eriko Ohgitani</dc:creator>
      <dc:creator>Marina Pizzi</dc:creator>
      <dc:creator>Yoshihiro Sowa</dc:creator>
      <dc:creator>Osam Mazda</dc:creator>
      <dc:date>2020-07-01</dc:date>
      <dc:source>ACS chemical neuroscience</dc:source>
      <dc:title>Raman Probes for &lt;em&gt;In Situ&lt;/em&gt; Molecular Analyses of Peripheral Nerve Myelination</dc:title>
      <dc:identifier>pmid:32603086</dc:identifier>
      <dc:identifier>doi:10.1021/acschemneuro.0c00284</dc:identifier>
    </item>
    <item>
      <title>Integration of metabolomics and proteomics to highlight altered neural development related pathways in the adult offspring after maternal folic acid supplement</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32571678/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>CONCLUSIONS: We conceive that the alterations of metabolites and protein in the offspring are associated with the maternal FA supplement and these alterations are involved in the neural development, although such animal data are limited in their ability to mimic metabolic outcomes in humans.</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Clin Nutr. 2021 Feb;40(2):476-487. doi: 10.1016/j.clnu.2020.05.042. Epub 2020 Jun 4.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND & AIMS: Maternal folic acid (FA) supplement (FolS) programs the early development of an offspring. The onset of complex diseases at a later stage of life has been evidently linked with maternal FA ingestion. However, little is known regarding the underlying molecule fingerprints of the offspring. Here, we analyze the influence of maternal FolS on the metabolism of the adult offspring rats using the integrated metabolomics-proteomics.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Twenty pregnant female rats were randomly assigned to a FA supplement (FolS group) or control group which were fed AIN93G diet with 2 or 5 mg/kg FA, respectively. The blood samples from the offspring at 0, 3 and 7 weeks after birth were collected. The brain samples were obtained from the offspring at 7 weeks after birth. Serum and brain metabolite profiles were performed by UPLC-MS/MS and the brain proteomics analysis was obtained using iTRAQ-based quantitative proteomics.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The metabolic change of the offspring for the maternal FA supplement is characterized by the phospholipids, fatty acid and amino acids, which are involved in linoleic acid, docosahexaenoic acid, glycerophosphocholine, lysophosphatidylcholine, tryptophan, glycine, arachidonic acid, γ-aminobutyric acid, and so on. Using iTRAQ-based quantitative proteomics analysis, 51 differential proteins in the brain are identified, which provides valuable insight into the underlying mechanisms of the offspring after the maternal FolS. These results demonstrate neural development related metabolites and proteins, such as docosahexaenoic acid, glycine, tryptophan, γ-aminobutyric acid, dopaminergic synapse related proteins including G protein, PPP1R1B and CAMK2G, are significantly altered, which suggests that the active neural conduction occurs in the offspring after maternal FA supplement. The behavioral testing demonstrates that the high level of memory is observed in rats with FA supplement.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: We conceive that the alterations of metabolites and protein in the offspring are associated with the maternal FA supplement and these alterations are involved in the neural development, although such animal data are limited in their ability to mimic metabolic outcomes in humans.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32571678/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32571678</a> | DOI:<a href=https://doi.org/10.1016/j.clnu.2020.05.042>10.1016/j.clnu.2020.05.042</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32571678</guid>
      <pubDate>Wed, 24 Jun 2020 06:00:00 -0400</pubDate>
      <dc:creator>Liyan Liu</dc:creator>
      <dc:creator>Zhipeng Liu</dc:creator>
      <dc:creator>Ying Li</dc:creator>
      <dc:creator>Changhao Sun</dc:creator>
      <dc:date>2020-06-24</dc:date>
      <dc:source>Clinical nutrition (Edinburgh, Scotland)</dc:source>
      <dc:title>Integration of metabolomics and proteomics to highlight altered neural development related pathways in the adult offspring after maternal folic acid supplement</dc:title>
      <dc:identifier>pmid:32571678</dc:identifier>
      <dc:identifier>doi:10.1016/j.clnu.2020.05.042</dc:identifier>
    </item>
    <item>
      <title>α-Synuclein-112 Impairs Synaptic Vesicle Recycling Consistent With Its Enhanced Membrane Binding Properties</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32548120/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Synucleinopathies are neurological disorders associated with α-synuclein overexpression and aggregation. While it is well-established that overexpression of wild type α-synuclein (α-syn-140) leads to cellular toxicity and neurodegeneration, much less is known about other naturally occurring α-synuclein splice isoforms. In this study we provide the first detailed examination of the synaptic effects caused by one of these splice isoforms, α-synuclein-112 (α-syn-112). α-Syn-112 is produced by an...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Front Cell Dev Biol. 2020 May 29;8:405. doi: 10.3389/fcell.2020.00405. eCollection 2020.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Synucleinopathies are neurological disorders associated with α-synuclein overexpression and aggregation. While it is well-established that overexpression of wild type α-synuclein (α-syn-140) leads to cellular toxicity and neurodegeneration, much less is known about other naturally occurring α-synuclein splice isoforms. In this study we provide the first detailed examination of the synaptic effects caused by one of these splice isoforms, α-synuclein-112 (α-syn-112). α-Syn-112 is produced by an in-frame excision of exon 5, resulting in deletion of amino acids 103-130 in the C-terminal region. α-Syn-112 is upregulated in the substantia nigra, frontal cortex, and cerebellum of parkinsonian brains and higher expression levels are correlated with susceptibility to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple systems atrophy (MSA). We report here that α-syn-112 binds strongly to anionic phospholipids when presented in highly curved liposomes, similar to α-syn-140. However, α-syn-112 bound significantly stronger to all phospholipids tested, including the phosphoinositides. α-Syn-112 also dimerized and trimerized on isolated synaptic membranes, while α-syn-140 remained largely monomeric. When introduced acutely to lamprey synapses, α-syn-112 robustly inhibited synaptic vesicle recycling. Interestingly, α-syn-112 produced effects on the plasma membrane and clathrin-mediated synaptic vesicle endocytosis that were phenotypically intermediate between those caused by monomeric and dimeric α-syn-140. These findings indicate that α-syn-112 exhibits enhanced phospholipid binding and oligomerization <i>in vitro</i> and consequently interferes with synaptic vesicle recycling <i>in vivo</i> in ways that are consistent with its biochemical properties. This study provides additional evidence suggesting that impaired vesicle endocytosis is a cellular target of excess α-synuclein and advances our understanding of potential mechanisms underlying disease pathogenesis in the synucleinopathies.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32548120/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32548120</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7272675/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7272675</a> | DOI:<a href=https://doi.org/10.3389/fcell.2020.00405>10.3389/fcell.2020.00405</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32548120</guid>
      <pubDate>Thu, 18 Jun 2020 06:00:00 -0400</pubDate>
      <dc:creator>Lindsey G Soll</dc:creator>
      <dc:creator>Julia N Eisen</dc:creator>
      <dc:creator>Karina J Vargas</dc:creator>
      <dc:creator>Audrey T Medeiros</dc:creator>
      <dc:creator>Katherine M Hammar</dc:creator>
      <dc:creator>Jennifer R Morgan</dc:creator>
      <dc:date>2020-06-18</dc:date>
      <dc:source>Frontiers in cell and developmental biology</dc:source>
      <dc:title>α-Synuclein-112 Impairs Synaptic Vesicle Recycling Consistent With Its Enhanced Membrane Binding Properties</dc:title>
      <dc:identifier>pmid:32548120</dc:identifier>
      <dc:identifier>pmc:PMC7272675</dc:identifier>
      <dc:identifier>doi:10.3389/fcell.2020.00405</dc:identifier>
    </item>
    <item>
      <title>Phosphoinositide Profile of the Mouse Retina</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32517352/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Phosphoinositides are known to play multiple roles in eukaryotic cells. Although dysregulation of phosphoinositide metabolism in the retina has been reported to cause visual dysfunction in animal models and human patients, our understanding of the phosphoinositide composition of the retina is limited. Here, we report a characterization of the phosphoinositide profile of the mouse retina and an analysis of the subcellular localization of major phosphorylated phosphoinositide forms in...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Cells. 2020 Jun 7;9(6):1417. doi: 10.3390/cells9061417.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Phosphoinositides are known to play multiple roles in eukaryotic cells. Although dysregulation of phosphoinositide metabolism in the retina has been reported to cause visual dysfunction in animal models and human patients, our understanding of the phosphoinositide composition of the retina is limited. Here, we report a characterization of the phosphoinositide profile of the mouse retina and an analysis of the subcellular localization of major phosphorylated phosphoinositide forms in light-sensitive photoreceptor neurons. Using chromatography of deacylated phosphatidylinositol headgroups, we established PI(4,5)P<sub>2</sub> and PI(4)P as two major phosphorylated phosphoinositides in the retina. Using high-resolution mass spectrometry, we revealed 18:0/20:4 and 16:0/20:4 as major fatty-acyl chains of retinal phosphoinositides. Finally, analysis of fluorescent phosphoinositide sensors in rod photoreceptors demonstrated distinct subcellular distribution patterns of major phosphoinositides. The PI(4,5)P<sub>2</sub> reporter was enriched in the inner segments and synapses, but was barely detected in the light-sensitive outer segments. The PI(4)P reporter was mostly found in the outer and inner segments and the areas around nuclei, but to a lesser degree in the synaptic region. These findings provide support for future mechanistic studies defining the biological significance of major mono- (PI(4)P) and bisphosphate (PI(4,5)P<sub>2</sub>) phosphatidylinositols in photoreceptor biology and retinal health.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32517352/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32517352</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7349851/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7349851</a> | DOI:<a href=https://doi.org/10.3390/cells9061417>10.3390/cells9061417</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32517352</guid>
      <pubDate>Thu, 11 Jun 2020 06:00:00 -0400</pubDate>
      <dc:creator>Stella Finkelstein</dc:creator>
      <dc:creator>Sidney M Gospe</dc:creator>
      <dc:creator>Kai Schuhmann</dc:creator>
      <dc:creator>Andrej Shevchenko</dc:creator>
      <dc:creator>Vadim Y Arshavsky</dc:creator>
      <dc:creator>Ekaterina S Lobanova</dc:creator>
      <dc:date>2020-06-11</dc:date>
      <dc:source>Cells</dc:source>
      <dc:title>Phosphoinositide Profile of the Mouse Retina</dc:title>
      <dc:identifier>pmid:32517352</dc:identifier>
      <dc:identifier>pmc:PMC7349851</dc:identifier>
      <dc:identifier>doi:10.3390/cells9061417</dc:identifier>
    </item>
    <item>
      <title>Structure-Activity Relationships of Butyrophilin 3 Ligands</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32453919/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Phosphoantigens (pAgs) are small phosphorus-containing molecules that stimulate Vγ9Vδ2 T cells with sub-nanomolar cellular potency. Recent work has revealed that these compounds work through binding to the transmembrane immunoglobulin butyrophilin 3A1 (BTN3A1) within its intracellular B30.2 domain. Engagement of BTN3A1 is critical to the formation of an immune synapse between cells that contain pAgs and the Vγ9Vδ2 T cells. This minireview summarizes the structure-activity relationships of pAgs...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">ChemMedChem. 2020 Jun 17;15(12):1030-1039. doi: 10.1002/cmdc.202000198. Epub 2020 May 26.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Phosphoantigens (pAgs) are small phosphorus-containing molecules that stimulate Vγ9Vδ2 T cells with sub-nanomolar cellular potency. Recent work has revealed that these compounds work through binding to the transmembrane immunoglobulin butyrophilin 3A1 (BTN3A1) within its intracellular B30.2 domain. Engagement of BTN3A1 is critical to the formation of an immune synapse between cells that contain pAgs and the Vγ9Vδ2 T cells. This minireview summarizes the structure-activity relationships of pAgs and their implications to the mechanisms of butyrophilin 3 activation leading to Vγ9Vδ2 T cell response.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32453919/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32453919</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7477806/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7477806</a> | DOI:<a href=https://doi.org/10.1002/cmdc.202000198>10.1002/cmdc.202000198</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32453919</guid>
      <pubDate>Wed, 27 May 2020 06:00:00 -0400</pubDate>
      <dc:creator>Andrew J Wiemer</dc:creator>
      <dc:date>2020-05-27</dc:date>
      <dc:source>ChemMedChem</dc:source>
      <dc:title>Structure-Activity Relationships of Butyrophilin 3 Ligands</dc:title>
      <dc:identifier>pmid:32453919</dc:identifier>
      <dc:identifier>pmc:PMC7477806</dc:identifier>
      <dc:identifier>doi:10.1002/cmdc.202000198</dc:identifier>
    </item>
    <item>
      <title>A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32452062/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Developmental synaptic remodeling is important for the formation of precise neural circuitry, and its disruption has been linked to neurodevelopmental disorders such as autism and schizophrenia. Microglia prune synapses, but integration of this synapse pruning with overlapping and concurrent neurodevelopmental processes, remains elusive. Adhesion G protein-coupled receptor ADGRG1/GPR56 controls multiple aspects of brain development in a cell type-specific manner: In neural progenitor cells,...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">EMBO J. 2020 Aug 17;39(16):e104136. doi: 10.15252/embj.2019104136. Epub 2020 May 25.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Developmental synaptic remodeling is important for the formation of precise neural circuitry, and its disruption has been linked to neurodevelopmental disorders such as autism and schizophrenia. Microglia prune synapses, but integration of this synapse pruning with overlapping and concurrent neurodevelopmental processes, remains elusive. Adhesion G protein-coupled receptor ADGRG1/GPR56 controls multiple aspects of brain development in a cell type-specific manner: In neural progenitor cells, GPR56 regulates cortical lamination, whereas in oligodendrocyte progenitor cells, GPR56 controls developmental myelination and myelin repair. Here, we show that microglial GPR56 maintains appropriate synaptic numbers in several brain regions in a time- and circuit-dependent fashion. Phosphatidylserine (PS) on presynaptic elements binds GPR56 in a domain-specific manner, and microglia-specific deletion of Gpr56 leads to increased synapses as a result of reduced microglial engulfment of PS<sup>+</sup> presynaptic inputs. Remarkably, a particular alternatively spliced isoform of GPR56 is selectively required for microglia-mediated synaptic pruning. Our present data provide a ligand- and isoform-specific mechanism underlying microglial GPR56-mediated synapse pruning in the context of complex neurodevelopmental processes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32452062/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32452062</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7429740/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7429740</a> | DOI:<a href=https://doi.org/10.15252/embj.2019104136>10.15252/embj.2019104136</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32452062</guid>
      <pubDate>Wed, 27 May 2020 06:00:00 -0400</pubDate>
      <dc:creator>Tao Li</dc:creator>
      <dc:creator>Brian Chiou</dc:creator>
      <dc:creator>Casey K Gilman</dc:creator>
      <dc:creator>Rong Luo</dc:creator>
      <dc:creator>Tatsuhiro Koshi</dc:creator>
      <dc:creator>Diankun Yu</dc:creator>
      <dc:creator>Hayeon C Oak</dc:creator>
      <dc:creator>Stefanie Giera</dc:creator>
      <dc:creator>Erin Johnson-Venkatesh</dc:creator>
      <dc:creator>Allie K Muthukumar</dc:creator>
      <dc:creator>Beth Stevens</dc:creator>
      <dc:creator>Hisashi Umemori</dc:creator>
      <dc:creator>Xianhua Piao</dc:creator>
      <dc:date>2020-05-27</dc:date>
      <dc:source>The EMBO journal</dc:source>
      <dc:title>A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding</dc:title>
      <dc:identifier>pmid:32452062</dc:identifier>
      <dc:identifier>pmc:PMC7429740</dc:identifier>
      <dc:identifier>doi:10.15252/embj.2019104136</dc:identifier>
    </item>
    <item>
      <title>Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/32392751/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&amp;fc=None&amp;ff=20220524190436&amp;v=2.17.6</link>
      <description>Parkinson's disease (PD) is the second most common neurodegenerative disease; it is characterized by the loss of dopaminergic neurons in the midbrain and the accumulation of neuronal inclusions, mainly consisting of α-synuclein (α-syn) fibrils in the affected regions. The prion-like property of the pathological forms of α-syn transmitted via neuronal circuits has been considered inherent in the nature of PD. Thus, one of the potential targets in terms of PD prevention is the suppression of α-syn...</description>
      <content:encoded><![CDATA[<div><p style="color: #4aa564;">Int J Mol Sci. 2020 May 7;21(9):3301. doi: 10.3390/ijms21093301.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Parkinson's disease (PD) is the second most common neurodegenerative disease; it is characterized by the loss of dopaminergic neurons in the midbrain and the accumulation of neuronal inclusions, mainly consisting of α-synuclein (α-syn) fibrils in the affected regions. The prion-like property of the pathological forms of α-syn transmitted via neuronal circuits has been considered inherent in the nature of PD. Thus, one of the potential targets in terms of PD prevention is the suppression of α-syn conversion from the functional form to pathological forms. Recent studies suggested that α-syn interacts with synaptic vesicle membranes and modulate the synaptic functions. A series of studies suggest that transient interaction of α-syn as multimers with synaptic vesicle membranes composed of phospholipids and other lipids is required for its physiological function, while an α-syn-lipid interaction imbalance is believed to cause α-syn aggregation and the resultant pathological α-syn conversion. Altered lipid metabolisms have also been implicated in the modulation of PD pathogenesis. This review focuses on the current literature reporting the role of lipids, especially phospholipids, and lipid metabolism in α-syn dynamics and aggregation processes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/32392751/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">32392751</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC7247581/?utm_source=Other&utm_medium=rss&utm_content=0bPECMi1Yk3QWA7wpSZZvhduU_UiN0m73sQgqE1m-Jq&ff=20220524190436&v=2.17.6">PMC7247581</a> | DOI:<a href=https://doi.org/10.3390/ijms21093301>10.3390/ijms21093301</a></p></div>]]></content:encoded>
      <guid isPermaLink="false">pubmed:32392751</guid>
      <pubDate>Wed, 13 May 2020 06:00:00 -0400</pubDate>
      <dc:creator>Akio Mori</dc:creator>
      <dc:creator>Yuzuru Imai</dc:creator>
      <dc:creator>Nobutaka Hattori</dc:creator>
      <dc:date>2020-05-13</dc:date>
      <dc:source>International journal of molecular sciences</dc:source>
      <dc:title>Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson's Disease</dc:title>
      <dc:identifier>pmid:32392751</dc:identifier>
      <dc:identifier>pmc:PMC7247581</dc:identifier>
      <dc:identifier>doi:10.3390/ijms21093301</dc:identifier>
    </item>
  </channel>
</rss>
